CURRICULUM VITAE NAME - University of Kansas Hospital€¦ · CURRICULUM VITAE NAME: ... Organizer...

CURRICULUM VITAE Susan E. Carlson, Ph.D.

1

Updated: December 2016

CURRICULUM VITAE NAME: Susan Elaine Anderson Carlson, Ph.D. AJ Rice Professor of Nutrition and Director,

Director, PhD Program in Medical Nutrition Science ADDRESS: Department of Dietetics and Nutrition, 4019 Delp, The University of Kansas Medical

Center, 3901 Rainbow Blvd., Kansas City, Kansas 66160-7600 BUSINESS: Phone: (913)-588-5359; fax: (913) 588-8946; [email protected] EDUCATION: High School: Columbia High School, White Salmon, Washington; Class Valedictorian Undergraduate:

Washington State University, Pullman, Washington 99613, B.S. 2/69 Major: Food and Nutrition USDI Student Research Trainee (Summers and Fall Semester 1966, Western Fish Nutrition Laboratory, Cook, Washington, 1964-1966

Graduate: Iowa State University, Ames, Iowa 50010, Ph.D. 8/75 (Attended 9/70-8/75) Major: Nutrition. Minors: Biochemistry, Physiology

Ph.D. Dissertation: Influence of meal pattern and dietary fat on cholesterol metabolism in adult rats recovering from undernutrition. Major Professor: Dr. Lotte Arnrich

Honors: Research Associate 9/70 – 8/74 Iowa State Graduate Dean Dissertation Award, 9/74 – 8/75

Postgraduate Training Awards (Competitive Grants Awarded): NIHLB Postdoctoral Fellow, Department of Pathology, University of Wisconsin, Madison, Wisconsin, 9/75 – 8/77

American Heart Association, Wisconsin Affiliate, Postdoctoral Fellow, Department of Pathology, University of Wisconsin, Madison, Wisconsin, 9/77 – 8/78

NIHLB Postdoctoral Fellow, Department of Pediatrics, University of South Florida, Tampa, Florida, 9/78 - 9/79

UNIVERSITY FACULTY APPOINTMENTS: 9/79 - 9/80 Assistant in Research (Faculty), Department of Pediatrics, University of South

Florida, Tampa, Florida 9/80 - 1/83 Assistant Professor, Department of Pediatrics, University of South

Florida, Tampa, Florida 1/83 - 9/86 Assistant Professor, Division of Newborn Medicine, Department of

Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi


2

9/84 - 9/86 Assistant Professor, Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi

9/86-6/95 Associate Professor, Departments of Pediatrics, Obstetrics and

Gynecology, and Biochemistry, The University of Tennessee, Memphis, Memphis, Tennessee

2/88-9/97 Associate Professor, Clinical Nutrition Program, Department of Consumer

Science and Education, College of Education, University of Memphis (formerly Memphis State University), Memphis, Tennessee

7/95-9/97 Professor, Departments of Pediatrics, Obstetrics and Gynecology, and

Biochemistry, The University of Tennessee, Memphis, Memphis, Tennessee

9/97-11/99 Professor, Schools of Nursing and Medicine (appointments in Pediatrics/Neonatology and Ob-Gyn), University of Missouri-KC, Kansas City, Missouri (UMKC Doctoral Faculty, April 1998).

11/99-4/08 Midwest Dairy Council Professor of Nutrition, School of Allied Health (Dept. of

Dietetics and Nutrition), School of Medicine (Dept. of Pediatrics) and School of Nursing, University of Kansas Medical Center, Kansas City, Kansas; Affiliate Professor in Obstetrics and Gyncecology, Univ. of Missouri-Kansas City, School of Medicine

4/08-present AJ Rice Professor of Nutrition, Department of Dietetics and Nutrition, Department

of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas; Affiliate Professor in Obstetrics and Gyncecology, Univ. of Missouri-Kansas City, School of Medicine

PROFESSIONAL SOCIETIES AND EDITORIAL BOARDS: American Society for Clinical Nutrition, 1984 – 2006 (was merged with the American Nutrition Society

in that year); Elections Committee, 1993; Publications Management Committee, 1999-2002, Consulting Editor for American Journal of Clinical Nutrition, 2005-2010

American Society for Nutrition (formerly American Society for Nutritional Sciences), 1984 – Present (Chairman: FASEB Mini-symposium, "Maternal Nutrition/Lactation," 1991; Chairman: FASEB Mini-symposium, "Infant Nutrition and Development," 1991; Chairman FASEB Mini-symposium: Maternal and Infant Nutrition, 1996; Chairman FASEB Mini-symposium on Methyl Donors, Iodine and DHA – Is Maternal Supplementation Beneficial?, 2008.

International Society for the Study of Fatty Acids and Lipids (Charter member), 1993 – Present. President (2012-2015), Past President (2015-2018). Board member 2004-present, President-elect (2009-2012), Local organizer for the 2008 International Meeting in Kansas City, MO (May 17-22).

American Pediatric Society, 1996 – Present (currently emeritus); Reviewed Abstracts for Pediatric Academic Societies Annual Meeting 2001, 2012 Southern Society for Pediatric Research, 1989-1997 European Journal of Lipid Science and Technology: Editorial Board, 2009-2017 International Society for Research on Human Milk and Lactation, 1989 – Present American Oil Chemists Society, 1991- 2006 (Committee to Select Editor-in-Chief of Lipids, 1994),


3

Member of Health and Nutrition Subsection, Member of Phospholipid Subsection (President, 2003-2005; Vice President 2001-2003, Secretary 1999-2001, Treasurer, 2001, symposium on Phospholipids in Nutrition for 2001 Annual Meeting, Workshop on Maternal and Infant LCPUFA for 2003 Annual Meeting)

Sigma Xi, 1974 - 2008 Phi Kappa Phi, 1974 – Present American College of Nutrition, 2000-2004 HONORS AND AWARDS: 1. Co-Chairman: Growth and Development in Infants, Second International Conference on the

Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, 1990 2. Plenary Lecture: Third Joint Meeting of the American and European Societies for Pediatric

Gastroenterology and Nutrition, 1990 3. Plenary Lecture/Scientific Advisory Board: Norwegian Academy of Science and Letters:

Omega-3 Fatty Acids: Metabolism and Biological Effects, 1992 4. Invited Lecturer: Fiftieth Anniversary of the Norwegian Council on Nutrition, Oslo, Norway,

August 29, 1996 5. Member organizing committee for “PUFA in Infant Nutrition: Consensus and Controversies,

American Oil Chemists' Society, Barcelona, Spain, November 7-9, 1996 6. PUFA in Maternal and Child Health, Organizer with Drs. Bert Koletzko, Robert Gibson, Ricardo

Uauy and Tom Clandinin, American Oil Chemist’s Society, Kansas City, MO, September 10-13, 2000

7. Named honorary Member American Dietetic Association for pioneering work in the role of DHA

in infant development, November 2002 8. Organized workshop on Harmonization of Infant Outcomes in Response to Variations in DHA

status, Kansas City, KS, November 2002. 9. Member organizing committee for AOCS Maternal and Infant LCPUFA Workshop , Kansas City,

MO, May 2003 10. Institute of Medicine/NRC Committee on Nutrient Relationships in Seafood, 2005-2006. 11. Local Organizer for the 2008 biennial meeting of the (International Society for the Study of Fatty

Acids and Lipids (Theme: From Lipidomics to Human Health) in Kansas City, MO, May 17-22, 2008.

12. Helen LeBaron Hilton Award (Iowa State University Alum) for research contributing to international health of families, 2009

13. March of Dimes Agnes Higgins Award, 2008 for pioneering research benefiting women and children


4

14. Executive Officer of the International Society for the Study of Fatty Acids and Lipids (President-

Elect 2009-2012; President 2012-2015, Past-President 2015-now)

15. Marge S. Sirridge, MD Excellence in Medicine and Science Award, KUMC Women in Medicine and Science 2016.

16. Iowa State University Distinguished Alumna, April 2017 EXTRAMURAL RESEARCH SUPPORT (direct costs); PI or shared PI unless denoted with *. 1. Infant Diets and Structural and Transport Lipids, March of Dimes Birth Defects Foundation April 1, 1981 - March 31, 1984, $47,000 2. Infant Diets and Structural and Transport Lipids, National Institutes of Heart Lung and Blood January 1, 1982 - December 31, 1984, $112,238 3. BRSG Grants, University of South Florida College of Medicine, $5,000 University of Mississippi Medical Center, $5,000 4. Docosahexaenoic Acid Supplementation of Preterm, Formula-fed Infants, Ross Laboratories September 1, 1985 - August 31, 1986, $30,000 5. Short- and Long-term Responses to Feeding Omega-3 Fatty Acid Supplemented Formula to

Premature Infants, Ross Laboratories, January 1, 1987 - December 31, 1989, $265,567 6. The Role of Dietary N-3 Fatty Acids in Premature Infants, National Institutes of Health (National

Eye Institute, R01 EY08770), January 1, 1990 - December 31, 1993, $335,121 7. Interaction Between Docosahexaenoate, Eicosapentaenoate, and Retinol Status on Red Blood

Cell, Plasma and Tracheal Aspirate Phospholipids, Fatty Acid Composition, and Eicosanoid Metabolism in Hospitalized Preterm Infants, Ross Laboratories, January 1, 1990 - December 31, 1991, $225,000

8. Role of Very Long Chain n-6 Supplementation With and Without n-3 Supplementation in Growth and Development of Preterm Infants, Ross Laboratories, July 1, 1992 – June 30, 2000, $420,000

9. The Role of Dietary N-3 Fatty Acids in Premature Infants, National Institutes of Health (National Institute of Child Health and Human Development, RO1 HD1329), September 1, 1993 – August 31, 1998, $427,442

10. Role of Specific Fatty Acids in Term Formula on Physical and Mental Development Mead Johnson Nutritional Group, September 1, 1995 - December 1, 1996, $100,000 11. Last Trimester DHA Supplementation Using DHA-Enriched Eggs, OmegaTech, Inc., Boulder,

CO, June 1 - December 31, 1996, $28,000 12. Last Trimester DHA Supplementation: Effect on Pregnancy Outcome, OmegaTech, Inc.,

Boulder, CO, July 1, 1998 – August 31, 2001, $316,132 13. Birth DHA Status and Effects on Infant Attention (Co-PI with John Colombo), OmegaTech, Inc.

(purchased by Martek Biosciences), Boulder, CO, Jan. 1, 2001-December 31, 2003, $242,335 14. The effects of infant formula supplemented with long chain polyunsaturated fatty acids on visual

and cognitive development in term infants. Mead Johnson Nutritionals, (Research Contract) ~$700,000. August 2003 – March 2007.

15. Models for studying individual components of human milk and relationships among those components as they relate to optimal formula. Mead Johnson Nutritionals (Research Contract), $250,364, March 1, 2004-March 1, 2007

16. *Levant (PI), Carlson (Co-investigator): Brain DHA, Dopamine, and Behavior: Roles in ADHD, NIH, $405,000, 2004-2007


5

17. *Levant (PI), Carlson (Co-I): Brain LC-PUFAS and Maternal Mental Health, NIH, $325,000, 2004-2006.

18. Carlson (PI): Contract to enroll toddlers in a compliance study. $176,580. July 2006-July 2007 21. Carlson (PI): Contract to enroll newborn infants in a study of diet and stool bacteria. $100,000,

July 07-July 08. 19. Carlson (PI), Colombo (Co-I): DHA and Pregnancy Outcome, NIH HD047315, $1,630,537, April

2006-Jan 31, 2012 (no cost extension from Feb 2011). 20. Carlson (PI), Colombo (Co-I):The effects of infant formula supplemented with long chain

polyunsaturated fatty acids on visual and cognitive development in term infants between 2 and 6 years of age. Mead Johnson Nutritional, (Research Contract). Funds awarded for 2005-2012 to follow infants studied to 18 mo under #14 above. $1,037,000.

21. Gustafson (PI), Carlson (Co-I) and other Co-Is. Effect of DHA supplementation on fetal heart rate and heart rate variability. NIH R21, 2009-2011.

22. Carlson (PI), Colombo (PI): DHA and Pregnancy Outcome, NIH HD047315, $1,612,037, Feb 2012-Jan 31, 2017.

23. Carlson (PI), Colombo (PI): Prebiotics in infant formula. Mead Johnson Nutrition, January 2014 – March 2016, $328,950

24. Carlson (PI/PD, RD): Biomedical Interdisciplinary Careers in Women’s Health Research K12, July 2010-July 2015, $2,500,000 (no cost extension to July 2016).

25. Carlson (PI, Gajewski (PI), Valentine (PI): Docosahexaenoic acid (DHA) supplementation in pregnancy to reduce early preterm birth. NIH HD083292, $2,536,594,1/19/2016 - 12/31/20.

26. Gustafson (PI): Prenatal DHA and Neurofunctional Development. NIH HD086001, 2,074,929, 4/2016-4/2021, Role: Co-I.

PATENTS Patent No. US 6,080,787, February 12, 2000: Methods and Compositions for Reducing the Incidence of Necrotizing Enterocolitis: S.E. Carlson, D.L. Ponder, M.B. Montalto, M.H. Dohnalek, J.D. Benson, D.A. Borror, D.V. Diodato. Patent No. US 6,306,908, Oct. 23, 2001: Methods for Reducing the Incidence of Necrotizing Enterocolitis: SE Carlson, DL Ponder, MB Montalto, MH Dohnalek, JD Benson, DA Borror, DV Diodato. US Patent Application (Attorney Docket 50625-0021), June 24, 2003: Nutritional Supplement: SE Carlson (withdrawn)

INTERNATIONAL/GOVERNMENT Institute of Food Technology member attendee (nongovernmental organization) to 37th CODEX meeting on Nutrition and Foods for Special Dietary Uses (CCFNSDU 37) (Germany), November 2015. Member US Delegation to the 38th CODEX meeting on Nutrition and Foods for Special Dietary Uses (CCFNSDU 37) (Hamburg, Germany), December 3-9, 2016. PANEL REVIEWER: U.S. Department of Agriculture - Human Nutrition, 1990 NIH: RFA-91-HD-10: Effect of Specific Components of Human Milk on the Nursling, 1991


6

U.S. Department of Agriculture - Peer review panelist for the Office of Scientific Quality Review (OSQR): ARS Project plans in National Program 107 Human Nutrition “Life Stage Nutrition and Metabolism, Beltsville, MD, November 3-4, 2008. NIH Kidney, Nutrition, Obesity and Diabetes Study Section, 2017- EDITORIAL AND EXPERT REVIEWS: American Journal of Clinical Nutrition (Consulting Editor – 2007-2012) European Journal of Lipid Science and Technology – Editor – 2008 to present Clinical Nutrition and Obesity (Editorial Board) (journal discontinued 2009) Update on Pediatrics (Editorial Board) Journal of Nutrition Journal of the American Medical Association European Journal of Clinical Nutrition American Society for Parenteral and Enteral Nutrition Journal of Pediatric Gastroenterology and Nutrition Lipids Journal of Lipid Research Proceedings of the Society for Experimental Biology and Medicine Journal of Pediatrics Pediatric Research Pediatrics Acta Paediatrica Scandinavica National Academy of Sciences New England Journal of Medicine New York Academy of Sciences World Health Organization National Science Foundation Journal of Comparative Physiology Journal of Human Lactation Nutritional Neuroscience Journal of the American Medical Association Review ~40 manuscripts/year for pediatric, lipid, medicine and nutrition journals PAST AND CURRENT CONSULTING Wyeth-Ayerst Hoffman La Roche Bristol Myers Squibb Scientific Therapeutics Information, Inc International Life Sciences Institute Child Health Foundation US Health Connect 2004 Mead Johnson Nutrition OmegaTech (became Martek Bioscience, which became DSM) Glaxo Smith Klein Plum Organics Sequoia WhiteWave Foods


7

PEER-REVIEWED RESEARCH REPORTS AND INVITED EDITORIALS: 1. Carlson SE, Goldfarb S: A sensitive enzymatic method for the determination of free and

esterified tissue cholesterol. Clinica Chimica Acta 79:575-582, 1977. 2. Carlson SE, Shriver CN, Arnrich L: Dietary fat and cholesterol metabolism in adult rats

undergoing rapid tissue repletion. Journal of Nutrition 108:1170-1179, 1978. 3. Carlson SE, Arnrich L: Influence of dietary lipids and meal pattern on body composition and

lipogenesis in adult rats. Journal of Nutrition 108:1162-1169, 1978. 4. Carlson SE, Mitchell AD, Goldfarb S: Sex-related differences in diurnal activities and

development of hepatic microsomal HMG-CoA reductase and cholesterol 7a-hydroxylase activities. Biochimica et Biophysica Acta 531:115-124, 1978.

5. Mitchell AD, Carlson SE, McGibbon WH, Goldfarb S: Cholesterol metabolism in normal and

restricted-ovulator chickens before and after sexual maturation. Atherosclerosis 32:11-21, 1979.

6. Carlson SE, Mitchell AD, Carter M, Goldfarb S: The effect of physiologic levels of circulating

estrogens and early sex-imprinting on post-pubertal hepatic microsomal 3-hydroxy-3-methylglutaryl CoA reductase activity in male and female rats. Biochimica et Biophysica Acta 633:154-161, 1980.

7. Carlson SE, DeVoe PW, Barness LA: The effect of human milk and infant formulas with

different polyunsaturated to saturated fat ratios on circulating high density lipoproteins. Journal of Pediatric Gastroenterology and Nutrition 1:303-309, 1982.

8. Putnam JC, Carlson SE, DeVoe PW, Barness LA: The effect of variations in dietary fatty acids

on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants. American Journal of Clinical Nutrition 36:106-114, 1982.

9. Carlson SE, Barness LA. Protein and energy requirements of term and preterm infants. J

Pediatr Gastroenterol Nutr 1983; 2 (Suppl 1): S81-7. 10. Carlson SE: N-acetylneuraminic acid concentrations in human milk oligosaccharides and

glycoproteins during lactation. American Journal of Clinical Nutrition 41:720-726, 1985. 11. Carlson SE. Human milk nonprotein nitrogen: occurrence and possible functions. Adv Pediatr

1985;32:43-70. 12. Carlson SE, House SG: Oral and intraperitoneal administration of N-acetylneuraminic acid:

Effect on rat cerebral and cerebellar N-acetylneuraminic acid. Journal of Nutrition 116:881-886, 1986.


8

13. Carlson SE, Carver JD, House SG: High fat diets varying in ratios of polyunsaturated to

saturated fat and linolenic acid: A comparison of rat neural and red cell membrane phospholipid. Journal of Nutrition 116:718-725, 1986.

14. Carlson SE, Rhodes PG, Ferguson MG: Docosahexaenoic acid status of preterm infants at

birth and following feeding with human milk or formula. American Journal of Clinical Nutrition 44:798-804, 1986.

15. Carlson SE, Rhodes PG, Rao V, Goldgar DE: Effect of fish oil supplementation on the omega-3

fatty acid content of red blood cell membranes in preterm infants. Pediatric Research 21:507-510, 1987.

16. Liu C-CF, Carlson SE, Rhodes PG, Rao V, Meydrech EF: Increase in plasma phospholipid

docosahexaenoic and eicosapentaenoic acids as a reflection of their intake and mode of administration. Pediatric Research 22:292-296, 1987.

17. Caldwell EJ, Carlson SE, Palmer SM, Rhodes PG: Histamine and ascorbic acid: A survey of

women in labor at term and significantly before term. International Journal of Vitamin and Nutrition Research 58:319-325, 1988.

18. Carlson SE, Salem N Jr. Essentiality of omega 3 fatty acids in growth and development of infants. World Rev Nutr Diet 1991; 66:74-96.

19. Salem N Jr, Carlson SE. Growth and development of infants. World Rev Nutr Diet 1991; 66:2-5. 20. Carlson SE. Plasma cholesterol and lipoprotein levels during fetal development and infancy.

Ann NY Acad Sci 1991; 623:81-9. 21. Peeples JM, Carlson SE, Werkman SH, Cooke RJ: Vitamin A status of preterm infants during

infancy. American Journal of Clinical Nutrition 53:1455-1459, 1991. 22. Rhodes PG, Reddy NS, Downing G, Carlson SE: Effects of different levels of intravenous a-

linolenic acid and supplemental breast milk on red blood cell docosahexaenoic acid in very low birth-weight infants. Journal of Pediatric Gastroenterology and Nutrition 13:67-71, 1991.

23. Carlson SE, Cooke RJ, Rhodes PG, Peeples JM, Werkman SH, Tolley EA: Long-term feeding

of formulas high in linolenic acid and marine oil to very low birth weight infants: Phospholipid fatty acids. Pediatric Research 30(5):404-412, 1991.

24. Carlson SE, Cooke RJ, Rhodes PG, Peeples JM, Werkman SH: Effect of vegetable and marine

oils in preterm infant formulas on blood arachidonic and docosahexaenoic acids. Journal of Pediatrics 120(4):S159-S167, 1992.

25. Carlson SE, Cooke RJ, Werkman SH, Tolley EA: First year growth of preterm infants fed

standard compared to marine oil n-3 supplemented formula. Lipids 27:901-907, 1992. 26. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA: Arachidonic acid status

correlates with first year growth in preterm infants. Proceedings of the National Academy of Sciences 90:1073-1077, 1993.


9

27. Carlson SE, Werkman SH, Rhodes PG, Tolley EA: Visual acuity development in healthy preterm infants: Effect of marine oil supplementation. American Journal of Clinical Nutrition 58:35-42, 1993.

28. Rose J, gibbons K, Carlson SE, Koo WW. Nutrient needs of the preterm infant. Nutr Clin Pract

1993; 8:226-32. 29. Werkman SH, Peeples JM, Cooke RJ, Tolley EA, Carlson SE: Effect of vitamin A

supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutrition 59:586-592, 1994.

30. Carlson SE, Werkman SH, Peeples JM, Wilson WM III: Long chain fatty acids and early visual

and cognitive development of preterm infants. European Journal of Clinical Nutrition 48: S27-S30, 1994.

31. Carlson SE: Lessons learned from randomizing infants to marine oil-supplemented formulas in

nutrition trials. Journal of Pediatrics 125: S33-S38, 1994. 32. Carlson SE, Werkman SH, Peeples JM, Wilson WM 3rd. Growth and development of premature

infants in relation to omega 3 and omega 6 fatty acid status. World Rev Nutr Diet 1994; 75:63-9.

33. Craig-Schmidt MC, Carlson SE, Crocker L, Sibai BM. Plasma total phospholipid arachidonic acid and eicosapentaenoic acid in normal and hypertensive pregnancy. World Rev Nutr Diet 1994; 76:126-9.

34. Carlson SE, Peeples JM, Werkman SH, Koo WWK: Plasma retinol and retinol binding protein

concentrations in premature infants fed preterm formula past hospital discharge. European Journal of Clinical Nutrition 49:134-136, 1995.

35. Rajaram S, Carlson SE, Koo WWK, Kelly DP, Rangachari A: Insulin-like growth factor (IGF)-I

and IGF-binding protein 3 during the first year in term and preterm infants. Pediatric Research 37(5):581-585, 1995.

36. Rajaram S, Carlson SE, Koo WWK, Braselton EW: Plasma mineral concentrations in preterm

infants fed a nutrient-enriched formula after hospital discharge. Journal of Pediatrics 126:791-796, 1995.

37. Werkman SH, Carlson SE: A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until 9 months. Lipids 31(1):91-97, 1996.

38. Carlson SE, Werkman SH: A randomized trial of visual attention of preterm infants fed

docosahexaenoic acid until 2 months. Lipids 31(1):85-90, 1996. 39. Carlson SE, Ford AJ, Werkman SH, Peeples JM, Koo WWK: Visual acuity and fatty acid status

of term infants fed human milk and formula with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatric Research 39:882-886, 1996.

40. Carlson SE: Arachidonic acid status of human infants: Influence of gestational age at birth and

diets with very long chain n-3 and n-6 fatty acids. Journal of Nutrition 126:1092S-1098S, 1996.


10

41. Carlson SE, Werkman SH, Tolley EA: The effect of long chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. American Journal of Clinical Nutrition 63:687-697, 1996.

42. Koo WWK, Walters J, Bush AJ, Chesney RW, Carlson SE: Dual energy x-ray absorptiometry

studies of bone mineral status in newborn infants. Journal of Bone and Mineral Research 11(7):997-1002, 1996.

43. Kretchmer N, Beard JL, Carlson SE: The role of nutrition in the development of normal

cognition. American Journal of Clinical Nutrition 63:997S-1001S, 1996. 44. Carlson SE, Clandinin MT, Cook H, Emken EA, Filer LJ: Trans fatty acids: Infant and fetal

development: Report of the Expert Panel on Trans Fatty Acids and Early Development. American Journal of Clinical Nutrition 66:1S-20S, 1997.

45. Carlson SE: Invited editorial: Functional effects of increasing n-3 fatty acid intake. Journal of

Pediatrics 131:173-175, 1997. 46. Koo WWK, Bush AJ, Walters J, Carlson SE. Postnatal development of bone mineral status

during infancy. Journal of the American College of Nutrition 17:65-70, 1998. 47. Carlson SE, Montalto MB, Ponder DL, Werkman SH, Korones SB. Lower necrotizing

enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr Res 44:491-498, 1998.

48. Carlson SE, Neuringer M. Polyunsaturated fatty acid status and neurodevelopment: A summary

and critical analysis of the literature. Lipids 34:171-178, 1999. 49. Carlson SE: Long chain polyunsaturated fatty acids and development of human infants. Acta

Paed Scand 88:72-77, 1999. 50. Carlson SE: Behavioral methods used in the study of long-chain polyunsaturated fatty acid

nutrition in primate infants. American Journal of Clinical Nutrition 71 (suppl.):268S-274S, 2000. 51. Tolley EA, Carlson SE: Considerations of statistical power in studies of visual development and

DHA status. Invited editorial. Am J Clin Nutr 71:1-2, 2000. 52. Carlson SE: Consumption of contaminated lake fish and reproduction. Invited editorial.

Epidemiology 11:374-5, 2000 53. Koletzko B, Agostoni C, Carlson SE, Clandinin T, Hornstra G, Neuringer M, Uauy R, Yamashiro

Y, Willatts P. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development (Report of Workshop sponsored by the Child Health Foundation), Acta Paediatr Scandinavica 90: 460-464, 2001.

54. Lapillone A, Carlson SE: Polyunsaturated fatty acids and infant growth. Lipids 2001; 36:901-

911. 55. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE: A randomized trial of

docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101: 469-479.


11

56. Sullivan D, Carlson SE. Dietary fats for infants and children. Pediatr Ann 2001;30: 683-93. 57. Smuts CM, Peeples JM, Borod E, Carlson SE. High-docosahexaenoic acid eggs: Feasibility as

a means to enhance mother and infant DHA status. Lipids 2003; 38:407-414. 58. Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development

alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004; 152:49-57.

59. Colombo J, Kannass KN, Shaddy DJ, Kundurthi S, Maikranz JM, Carlson SE. Maternal DHA

and the development of attention in infancy and toddlerhood. Child Development 2004; 75:1254-1267.

60. Gaines J, Berman N, Carlson SE. Reduced Brain Docosahexaenoic Acid During Development.

In Unraveling Lipid Metabolism with Microarrays and Metabolomics (Berger A, Roberts M, eds). Marcel Dekker, 2004.

61. Levant B, Crane JF, Carlson SE. Sub-chronic antipsychotic drug treatment does not alter brain

phospholipid fatty acid composition in rats. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:728-732.

62. Levant B, Radel JD, Carlson SE. Reduced brain DHA content after a single reproductive cycle

in female rates fed a diet deficient in n-3 polyunsaturated fatty acids. Biol Psych 2006; 60:987-90.

63. Cheatham C, Colombo J, Carlson SE. Omega-3 fatty acids and visual and cognitive function.

Am. J. Clin. Nutr. 2006; 83:1458S-66S. 64. Levant B, Ozias MK, Carlson SE. Sex-specific effects of brain LC-PUFA composition on

locomotor activity in rats. Physiol Behavi 2006; 89:196-204.

65. Levant B, Ozias MK, Carlson SE. Diet (n-3) Polyunsaturated Fatty Acid Content and Parity Interact to Alter Maternal Rat Brain Phospholipid Fatty Acid Composition, J. Nutr 2006; 136:2236-42.

66. Levant B, Ozias MK, Jones, AK, Carlson SE. Differential Effects of Modulation of Brain

Docosahexaenoic Acid Content During Development in Specific Regions of Rat Brain, Lipids 2006; 41:407-414.

67. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function:

potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 2006; 75:329-49.

68. Ozias MK, Carlson SE, Levant B. Maternal parity and diet (n-3) polyunsaturated fatty acid

concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J. Nutr. 2007; 137:125-9.


12

69. Levant B, Ozias MK, Carlson SE. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J. Nutr. 2007; 137:130-4.

70. Levant B, Ozias MK, Carlson SE. Diet (n-3) polyunsaturated fatty acid content and parity affect

liver and erythrocyte phospholipid fatty acid composition in female rats. J Nutr 2007;137: 2425-30.

71. Gajewski BJ, Simon SD, Carlson SE. Predicting accrual in clinical trials with a Bayesian

posterior predictive distribution, Statistics in Medicine 2008;27:2328-40. 72. Aupperle RL, Denney DR, Lynch SG, Carlson SE, Sullivan DK. “Omega-3 fatty acids and

multiple sclerosis: Relationship to depression. J Behav Med 2008; 31:127-35. 73. Gustafson KM, Colombo J, Carlson SE. Docosahexaenoic acid and cognitive function: Is the

link mediated by the autonomic nervous system? Prostaglandins Leukot Essent Fatty Acids 2008;79: 135-40.

74. Levant B, Ozias MK, Davis PF, Winter M, Russell KL, Carlson SE, Reed GA, McCarson KE.

Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. Psychoneuroendocrinology 2008;33: 1279-92.

75. Gajewski, B, Simon, S, and Carlson, S. Predicting accrual in clinical trials with Bayesian

posterior predictive distributions, Statistics in Medicine 2008; 27(13), 2328-2340. 76. Kannass KN, Colombo C, Carlson SE. Maternal DHA levels and toddler free play attention.

Developmental Neuropsych 2009;34: 159-174. 77. Carlson SE. Docosahexaenoic Acid Supplementation in Pregnancy and Lactation: A Review.

Am J Clin Nutr 2009; 89:678S-84S. 78. Carlson SE. Early determinants of development: A Lipid Perspective. Am J Clin Nutr 2009;

89:1523S-1529S. 79. Birch EE, Carlson SE, Hoffman DR. Fitzgerald-Gustafson KM, et al. The DIAMOND (DHA

intake and measurement of neural development) Study: A double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010, 91:848-59.

80. Minns LM, Kerling EH, Neely MR, Sullivan DK, Wampler JL, Harris CL, Berseth CL, Carlson SE.

Toddler formula supplemented with docosahexaenoic acid (DHA) improves DHA status and respiratory health in a randomized, double-blind, controlled trial of US children less than 3 years of age. Prostaglandins, Leukotrienes and Essential Fatty Acids 2010, 82:287-93.

81. Carlson, S., Carvajal, R., Coutrelis, N., Desjeus J.F., Morelli, L., Weir, C., Tops, A., & Van Dael,

P. Publish and perish: a disturbing trend in the European Union’s regulation of nutrition health claims made on food. FDLI Update. Sept-October 2010.


13

82. Carlson, S., Carvajal, R., Coutrelis, N., Dejeus J.F., Morelli, L., Weir, C., Tops, A., & Van Dael, P. Protection of proprietary data. European Food and Feed Law Review, 5(3), 2010.

83. Davis PF, Ozias MK, Carlson SE, Reed GA, Winter MK, McCarson KE, Levant B. Dopamine

receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr Neurosci 2010; 13:161-9.

84. Xu M, Wang W, Frontera JR, Neely MC, Lu JJ, Aires D, Hsu FF, Turk J, Swerdlow RH, Carlson

SE, Zhu H. Ncb5or deficiency increases fatty acid catabolism and oxidative stress. J Biol Chem 2011; 286: 11141-54.

85. Colombo J, Carlson SE, Cheatham CL, Fitzgerald-Gustafson KM, Kepler A, Doty T. Long chain

polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr Res 2011; 70: 406-410.

86. Lauritzen L, Carlson SE. Maternal fatty acid status during pregnancy and lactation and relation

to newborn and infant status. Maternal and Child Nutrition 2011; 7:41-58. 87. Guo Y, Xu M, Deng B, Frontera JR, Kover KL, Aires D, Ding H, Carlson SE, Turk J, Wang W,

Zhu H. Beta-cell injury in NcB5or-null mice is exacerbated by consumption of a high-fat diet. Eur J Lipid Sci Technol. 2012; 114:233-243.

88. Colombo J, Carlson SE. Is the measure the message: The BSID and nutritional interventions.

Invited commentary. Pediatrics 2012; 129:1166-7. 89. Robinson DT, Carlson SE, Murthy K, Frost B, Li S, Caplan M. Docosahexaenoic and

arachidonic acid levels in extremely low birth weight infants with prolonged exposure to intravenous lipids. J Pediatr 2013; 162:56-61.

90. Scholtz SA, Gottipati BS, Gajewski BJ, Carlson SE. Dietary sialic acid and cholesterol influence

cortical composition in developing rats. J Nutrition 2013; 143:132-5. 91. Gajewski, BJ, Simon, SD and Carlson, SE. On the existence of constant accrual rates in clinical

trials and direction for future research. International Journal of Statistics and Probability 2012, 1: p43-).

92. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley

LA, Kerling EH, Shaddy DJ. Docosahexaenoic acid supplementation and pregnancy outcomes. Am J Clin Nutr 2013; 97:808-15.

93. Gustafson KM, Carlson SE, Colombo J, Yeh HW, Shaddy DJ, Li S, Kerling EH. Effects of

docosahexaenoic acid supplementation during pregnancy on fetal heart rate and variability: a randomized clinical trial. Prostaglandins Leukot and Essent Fatty Acids 2013; 88:331-8.

94. Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM, Gustafson KM,

Brez C. Long term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 2013; 98:1-10.


14

95. Scholtz SA, Colombo J, Carlson SE. Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period. Nestle Nutr Inst Workshop Ser 2013; 77:145-54.

96. Hull HR, Carlson SE. Cognition. World Rev Nutr Diet 2014; 109:36-53. 97. Nollen NL, Mayo MS, Carlson SE, Rapoff MA, Goggin KJ, Ellerbeck EF. Mobile technology for

obesity prevention: a randomized pilot study in racial- and ethnic-minority girls. Am J Prev Med 2014; 46:404-8.

98. Brenna JT, Carlson SE. Docosahexaenoic acid and human brain development: Evidence that a

dietary supply is needed for optimal development. J Hum Evol 2014; 77:99-106. 99. Ozias MK, Kerling EH, Christifano D, Scholtz SA, Colombo J, Carlson SE. Typical prenatal

vitamin D supplement intake does not prevent decrease of plasma 25-hydroxyvitamin D at birth. J Am Coll Nutr 2014, 33:394-9.

100. Koletzko B, Boey CC, Campoy C, Carlson SE, Chang N, et al. Current information and Asian

perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation, and infancy: systematic review and practice recommendations form an early nutrition academy workshop. Ann Nutr Metab 2014; 65:49-80.

101. Scholtz SA, Kerling EH, Shaddy DJ, Li S, Thodosoff JM, Colombo J, Carlson SE.

Docosahexaneoic acid (DHA) supplementation in pregnancy differentially modulates arachidonic acid and DHA status across FADS genotypes in pregnancy. PLEFA 2015; 94:29-33.

102. Ozias MK, Li S, Hull HR, Brooks WM, Petroff MG; Carlson SE. Abdominal visceral adiposity influences CD4+ T cell cytokine production in pregnancy. Cytokine 2015, 71:405-8.

103. Ozias MK, Li S, Hull HR, Brooks WM, Carlson SE. Relationship of circulating adipokines to body

composition in pregnant women. Adipocyte 2014; 4:44-9. 104. Currie LM, Tolley EA, Thodosoff JM, Kerling EH, Sullivan DK, Colombo J, Carlson SE. Long

chain polyunsaturated fatty acid supplementation in infancy increases length- and weight-for-age but not BMI to 6 years when controlling for the effects of maternal smoking. PLEFA 2015; 98:1-6

105. Koletzko B, Carlson SE, van Goudoever JB. Should infant formula provide both omega-3 DHA

and omega-6 arachidonic acid? Ann Nutr Metab 2015; 66:137-8. 106. Hidaka BH, Li S, Harvey KE, Carlson SE, Sullivan DK, Kimler BF, Zailes CM, Fabian CJ.

Omega-3 and omega-6 fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology. Cancer Prev Res 2015; 8:359-64.

107. Pateva IB, Kerling EH, Reddy M, Chen D, Carlson SE, Tancabelic. Effect of maternal cigarette

smoking on newborn iron stores. J. Clin Res Trials 2015; 1:4-7. 108. Ford NA, Rossi EL, Barnett K, Yang P, Bowers LW, Hidaka B, Kimler BF, Carlson SE, Shureiqi

I, deGraffenried LA, Fabian CJ, Hursting SD. Omega-3-acid ethyl esters block the


15

protumorigenic effects of obesity in mouse models of postmentopausal basal-like and claudin low breast cancer. Cancer Prev Res 2015; 8:796-806.

109. Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kretuzjans AL, Carlson SE et al. Modulation of

breast cancer risk biomarkers by high dose omega-3 fatty acids: Phase II Pilot study in postmenopausal women. Cancer Prev Res 2015; 8:922-31.

110. Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kretuzjans AL, Carlson SE et al. Modulation of

breast cancer risk biomarkers by high dose omega-3 fatty acids: Phase II Pilot study in premenopausal women. Cancer Prev Res 2015; 8:912-21.

111. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid in US adults in the last half

century. Advances in Nutrition 2015; 6:660-4. 112. Gajewski BJ, Reese CS, Colombo J, Carlson SE. Commensurate priors on a finite mixture

model for incorporating repository data in clinical trials. Stats in Biopharmaceutical Res 2015, 2:1-10.

113. Foiles AM, Kerling EH, Wick JA, Scalabrin DMF, Colombo J, Carlson SE. Formula with long

chain polyunsaturated fatty acids reduces incidence of allergy in early childhood. J Pediatr Allergy and Immunology 2016; 27:156-61.

114. Raiten DJ, Steiber AL, Carlson SE, Griffin I. Anderson D, et al. Working group reports:

evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B project. Am J Clin Nutr 2016; 103:648S-78S.

115. Taylor JM, Hamilton-Reeves JM, Sullivan DK, Gibson GA, Creed C, Carlson SE, Wesson DE,

Grantham JJ. Diet and polycystic kidney disease: A pilot intervention study. Clin Nutr 2016; Jan 11 (epub ahead of print).

116. Kerling EH, Souther LM, Gajewski BJ, Sullivan DK, Georgieff MK, Carlson SE. Reducing iron

deficiency in 18-36-months-old US children – Is the solution less calcium? Maternal and Child Health Journal 2016; 20:1798-803.

117. Liao K, McCandliss BD, Carlson SE, Colombo J, Shaddy J, Kerling E, Lepping R, Sittiprapaporn

W, Cheatham CL, Gustafson KM. Event related potential differences in children supplemented with long-chain polyunsaturated fatty acids during infancy. Devel Sci 2016; in press.

118. Kothapalli KSD, Gadjil MS, Carlson SE, O’Brien KO, Ye K, Zhang JY, Park HG, Ojukwu K, Zou

J, Hyon SS, Joshi KS, Keinan A, Brenna JT. Molecular Biology and Evolution 2016; 33:726-39. 119. Shireman TI, Kerling EH, Gajewski BJ, Colombo J, Carlson SE. Docosahexaneoic acid

supplementation and the return on investment for pregnancy outcomes. PLEFA 2016, 111:8-10. 120. Colombo J, Gustafson KM, Gajewski BJ, Shaddy DJ, Kerling EH, Thodosoff JM, Doty T, Brez

CC, Carlson SE. Prenatal DHA supplementation and infant attention. Pediatr Res 2016; 80:656-62.


16

121. Robinson DT, Caplan M, Carlson SE, Yoder R, Murthy K, Frost B. Early docosahexaenoic and arachidonic acid supplementation in extremely-low-birth-weight infants. Pediatr Res 2016; 80:505-10.

122. Hidaka BH, Carlson SE, Kimler BF, Fabian CJ. Dietary associations with a breast cancer risk

biomarker depend on menopause status. Nutrition and Cancer 2016; 68:1115-22. 123. Lei Y, Carlson SE, Yelland L, Makrides M, Gibson R, & Gajewski BJ. Comparison of

Dichotomized and Distributional Approaches in Rare Event Clinical Trial Design: a Fixed Bayesian Design, Journal of Applied Statistics 2016 (in press).

124. Yelland LN, Gajewski BJ, Colombo J, Gibson RA, Makrides M, Carlson SE. Predicting the effect

of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. PLEFA 2016;112:44-9.

125. Taylor JM, Ptomey L, Hamilton-Reeves J, Sullivan D, Creed C, Carlson SE, Wesson D,

Grantham J, Gibson C. Experiences and perspectives of polycystic kidney disease patients following a diet of reduced osmoles, protein, and acid precursors supplemented with water: A qualitative study. PLoS ONE 2016 (in press).

126. Hidaka BH, Kerling EH, Thodosoff JM, Sullivan DK, Colombo J, Carlson SE. Dietary patterns of

early childhood and maternal socioeconomic status in a unique prospective sample from a randomized controlled trial of prenatal supplementation. BMC Pediatrics 2016; 16:191.

127. Carlson SE, Gajewski BJ, Valentine CJ, Rogers LK, Weiner CP, DeFranco EA, Buhimschi CS.

Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol. BMC Pregnancy and Childbirth 2017; 17:62.

128. Carlson SE, Colombo J. Docosahexaenoic acid and arachidonic acid nutrition in early

development. Adv Pediatr 2016; 63: 453-71. 129. Lei Y, Mayo MS, Carlson SE, Gajewski BJ. Personalized medicine enrichment design for DHA

supplementation clinical trial. Contemporary Clinical Trials Communications 2017; 5:116-122. 130. Taylor JM, Hamilton-Reeves JM, Sullivan DK, Gibson CA, Creed C, Carlson SE, Wesson DE,

Grantham JJ. Diet and polycystic kidney disease: A pilot intervention study. Clin Nutr 2017;36:458-66.

131. Hidaka BH, Kimler BF, Fabian CJ, Carlson SE. An empirically derived dietary pattern

associated with breast cancer risk is validated in a nested case-control cohort from a randomized primary prevention trial. Clin Nutr ESPEN 2017; 17:8-17.

Complete List of Published Work in MyNCBI/MyBibliography:

http://www.ncbi.nlm.nih.gov/sites/myncbi/susan.carlson.1/bibliography/41154439/public/?sort=date&direction=descending


17

CHAPTERS AND INVITED ARTICLES: 1. Curran JS, Carlson SE, Barness LA: Protein and energy requirements of full-term and low-

birth-weight infants. In Lebenthal E (ed.), Textbook of Gastroenterology and Nutrition in Infancy, New York, Raven Press, 1981, pp 265-274.

2. Carlson SE, Barness LA: Macronutrient requirements for growth. In Walker A, Watkins J

(eds.), Nutrition in Pediatrics--Basic Science and Clinical Aspects, Boston, Little Brown, 1985, pp 3-15.

3. Carlson SE: Human milk non-protein nitrogen: Occurrence and possible functions. Advances

in Pediatrics 32, 1985, pp 43-70. 4. Carlson SE: Breastfeeding and lipid metabolism. In The Breast-fed Infant: A Model for

Performance, 91st Ross Conference, 1986, pp 154-161. 5. Carlson SE, Rhodes PG: Docosahexaenoic acid status in infants: Effects of diet and

supplementation. In Lands WEM (ed.), Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids, Champaign, IL, American Oil Chemists Society, 1987, pp 491-494.

6. Carlson SE: Docosahexaenoic acid in mammalian development. In Infant Nutrition,

Development and Disease, Mead Johnson Symposium on Perinatal and Developmental Medicine, No. 31, Evansville, IN, Mead Johnson and Company, 1989, pp 26-31.

7. Carlson SE: Polyunsaturated fatty acids and infant nutrition. In Galli C, Simopoulos AP (eds.),

Dietary Omega 3 and Omega 6 Fatty Acids: Biological Effects and Nutritional Essentiality, New York, Plenum Publishing, 1989, pp 147-158.

8. Burghen GA, Carlson SE: Nutrition and nutritional disturbances. In Summitt RL (ed.),

Comprehensive Pediatrics, St. Louis, The C. V. Mosby Company, 1990, pp 150-168. 9. Carlson SE, Salem N: Essentiality of omega-3 fatty acids in growth and development of infants.

In Simopoulos AP, Kifer RR, Martin RE, Barlow SM (eds.), Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, World Review of Nutrition and Dietetics, Volume 66, Basel, Switzerland, Karger Publishing Press, 1991, pp 74-86.

10. Carlson SE: Plasma cholesterol and lipoprotein levels during fetal development and infancy. In

Williams CL, Wynder EL (eds.), Annals of the New York Academy of Sciences: Hyperlipidemia in Childhood and the Development of Atherosclerosis, Volume 623, New York, New York Academy of Sciences, 1991, pp 81-90.

11. Carlson SE: Are n-3 polyunsaturated fatty acids essential for growth and development? In

Nelson G (ed.), Proceedings of the AOCS Short Course on Health Effects of Dietary Fatty Acids, Champaign, IL, American Oil Chemists' Society, 1991, pp 42-49.


18

12. Carlson SE: Very long chain fatty acids in the developing retina and brain. In Polin R, Fox W (eds.), Fetal and Neonatal Physiology, Philadelphia, W. B. Saunders Company, 1991, pp 341-346.

13. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Wilson WM III: Plasma phospholipid

arachidonic acid and growth and development of preterm infants. In Koletzko B, Okken A, Rey J, Salle B, Van Biervliet JP (eds.), Recent Advances in Infant Feeding, Stuttgart-New York, Georg Thieme Verlag, 1992, pp 22-27.

14. Carlson SE, Cooke RJ, Peeples JM, Werkman SH, Tolley EA: Docosahexaenoate (DHA) and

eicosapentaenoate (EPA) supplementation of preterm (PT) infants: Effects on RBC and plasma n-3 and visual acuity. In Ghisolfi J, Putet G (eds.), Essential Fatty Acids and Infant Nutrition, Proceedings of the International Symposium, Paris, John Libbey Eurotext, 1992, pp 111-118.

15. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA, Wilson WM III: Growth and

development of very low-birthweight infants in relation to n-3 and n-6 essential fatty acid status. In Sinclair A, Gibson R (eds.), Essential Fatty Acids and Eicosanoids, Champaign, IL, AOCS Press, 1993, pp 192-196.

16. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Koo WWK, Tolley EA: The effect of marine

oil-supplemented formulas with and without eicosapentaenoic acid on the n-3 and n-6 fatty acid status and growth of premature infants. In Yasugi T, Nakamura H, Soma M (eds.), Advances in Polyunsaturated Fatty Acid Research, New York, Excerpta Medica, 1993, pp 261-264.

17. Rose J, Gibbons K, Carlson SE, Koo WWKK: Nutrient needs of the preterm infant. Nutrition in

Clinical Practice 8:226-232, 1993. 18. Carlson SE: Lipid requirements of very low birth weight infants for optimal growth and

development. In Dobbing J, Benson JD (eds.), Lipids, Learning and the Brain: Fats in Infant Formulas, Report of the 103rd Ross Conference on Pediatric Research, Columbus, OH, Ross Laboratories, 1993, pp 188-214.

19. Jensen RG, Bitman J, Carlson SE, Couch SC, Hamosh M, Newburg DS: Human milk lipids. In

The Handbook of Milk Composition, New York, Academic Press, 1994. 20. Carlson SE, Werkman SH, Peeples JM, Wilson WM III: Growth and development of premature

infants in relation to �-3 and �-6 fatty acid status. In Galli C, Simopoulos AP, Tremoli E (eds.), Fatty Acids and Lipids: Biological Aspects, World Review of Nutrition and Dietetics, Volume 75, Basel, Switzerland, S. Karger, 1994, pp 63-69.

21. Craig-Schmidt MC, Carlson SE, Crocker L, Sibai BM: Plasma total phospholipid arachidonic

acid and eicosapentaenoic acid in normal and hypertensive pregnancy. In Galli C, Simopoulos AP, Tremoli E (eds.), Fatty Acids and Lipids: Biological Aspects, World Review of Nutrition and Dietetics, Volume 76, Basel, Switzerland, S. Karger, 1994, pp 126-129.

22. Carlson SE, Koo WWK, Werkman SH: Omega-3 and omega-6 supplementation of infants:

Biochemistry, visual development and growth. In Proceedings of the Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology and Medicine, Dallas, TX, American Heart Association, 1995, pp 47-59.


19

23. Carlson SE: The role of PUFA in infant nutrition. INFORM 6(8):940-946, 1995. 24. Carlson SE: Perceptual and cognitive function: Methods of assessment and relation to

LCPUFA status during infancy. In Carlson SE, Neuringer M, Reisbick S, Assessment of Visual and Cognitive Function in Relation to Long Chain Polyunsaturated Fatty Acids, Basel, Switzerland, Hoffmann-La Roche, 1996, pp 49-69.

25. Carlson SE: A common sense approach to dietary lipids in infancy and childhood. International

Seminars in Paediatric Gastroenterology and Nutrition, Vol. 5, 1996. 26. Carlson SE, Barness LA: Macronutrient requirements for growth. In Walker A, Watkins J

(eds.), Nutrition in Pediatrics--Basic Science and Clinical Aspects, Hamilton, Ontario, B. C. Decker, 1997, pp 81-90.

27. Carlson SE: Long-chain polyunsaturated fatty acid supplementation of preterm infants. In

Dobbing J (ed.), Developing Brain and Behavior: The role of Lipids in Infant Formula, London, Academic Press Limited, 1997, pp. 41-102.

28. Carlson SE: Long chain polyunsaturated fatty acids in infants and children. Basel, Switzerland,

Annales Nestle, 1997;55:52-62.

29. Carlson SE: Very long chain fatty acids in the developing retina and brain. In Polin R, Fox W (eds.), Fetal and Neonatal Physiology, 2nd ed., Philadelphia, W. B. Saunders Company, 1998, pp. 504-514.

30. Forsyth JS, Carlson SE: Long-chain polyunsaturated fatty acids in infant nutrition: Effects on

infant development. Curr Opin Clin Nutr Metab Care 2001; 4:1-4. 31. Carlson SE: Long chain polyunsaturated fatty acid metabolism and possible implications for pre-

term infants. Neonatal Nutrition, ed. Richard Cooke. Seminars in Perinatology, 2001; 6: 437-449.

32. Sullivan D and Carlson SE: Fats for children. Pediatr Ann 2001; 30:683-693 33. Un S, Carlson SE: Very long chain fatty acids in the developing retina and brain. In Polin R,

Fox W (eds.), Fetal and Neonatal Physiology, 3rd ed., Philadelphia, W. B. Saunders Company, 2003.

34. Carlson SE. Postdischarge nutrition of preterm infants. In Nutrition Needs of the Preterm infants:

Scientific and Practical Guidelines (Ed: Tsang RC, et al.), Williams and Watkins, 2005. 35. Cheatham C, Colombo J, Carlson SE: Very long chain fatty acids in the developing retina and

brain. In Polin R, Fox W (eds.), Fetal and Neonatal Physiology, 4th ed., Philadelphia, W. B. Saunders Company, 2010.

36. Carlson SE, Cheatham C, Colombo J: Very long chain fatty acids in the developing retina and brain. In Polin R, Fox W (eds.), Fetal and Neonatal Physiology, 5th ed., Philadelphia, W. B. Saunders Company, 2016.


20

INVITED LECTURES: National: 1. Course Coordinator/Moderator: "Pediatric Lipid Metabolism", 13th Clinical Congress American Society for Parenteral and Enteral Nutrition, Miami Beach, Florida, February 5, 1989 2. "Issues Related to the Lipid Composition of Infant Formulas", 13th Clinical Congress, American

Society for Parenteral and Enteral Nutrition, Miami Beach, Florida, February 5, 1989 3. Chairman: Mini-Symposium "Pediatric Lipid Metabolism", Federation of American Societies for

Experimental Biology (American Institute of Nutrition/American Society for Clinical Nutrition), New Orleans, Louisiana, March 22, 1989 4. "Conditionally Essential Fatty Acids", American Society for Parenteral and Enteral Nutrition 14th

Clinical Conference, San Antonio, Texas, January 30, 1990 5. "Are N-3 Polyunsaturated Fatty Acids Essential for Growth and Development" American Oil Chemists' Society Short Course on Health Effects of Dietary Fatty Acids Baltimore, MD, April 19, 1990 6. "Long-term Docosahexaenoate (DHA) and Eicosapentaenoate (EPA) Supplementation of

Preterm Infants: Effects on Biochemistry, Visual Acuity, Information Processing, and Growth in Infancy", 81st American Oil Chemists' Society Annual Meeting, Baltimore, MD, April 24, 1990

7. "Plasma Lipoprotein Levels During Fetal Development and Infancy", New York Academy of Sciences Conference on Hyperlipidemia in Childhood and Development of Atherosclerosis, Bethesda, MD, May 1990

8. "Lipid Composition of Infant Formulas: Where Are We Now on the Issue of Very Long Chain n-6 and n-3 Fatty Acids?"American Society for Parenteral and Enteral Nutrition, 15th Clinical Congress, San Francisco, California, January 27, 1991

9. "Overview on Infant Nutrition and Development" and Chairperson: Minisymposia: "Maternal Nutrition/Lactation"; "Infant Nutrition and Development", Federation of American Societies for Experimental Biology (American Institute of Nutrition/American Society for Clinical Nutrition), Atlanta, Georgia, April 23, 1991

10. "Should Human Milk Lipids Be the Model for Lipids in Formulas Designed for Preterm Infants?" Departments of Animal Sciences and Nutritional Sciences, University of Vermont, Burlington,

Vermont, June 28, 1991 11. "Fatty Acid Requirements", Neonatal Nutrition, Children's Hospital of the Medical University of

South Carolina, Charleston, South Carolina, March 10, 1992 12. "Special Components for Infant Formulas", Neonatal Nutrition, Children's Hospital of the

Medical University of South Carolina, Charleston, South Carolina, March 11, 1992 13. "Necessary Nutrients in the Composition of Human Milk", 1992 International Lactation

Consultant Association Conference, Chicago, Illinois, July 9, 1992 14. "The Fatty Acid Profile of Preterm Formulas: Why All the Fuss?", Small Bundles: Nutritional

Support for the High Risk Infant, Orlando, Florida, April 3, 1993 15. "Effect of Early Feeding on Later Outcome", Small Bundles: Nutritional Support for the High

Risk Infant, Orlando, Florida, April 3, 1993 16. Seminar: "N-3 and N-6 Fatty Acid Status of Preterm Infants", Western Human Nutrition

Research Center (USDA), San Francisco, California, August 12, 1993 17. "Omega-3 and Omega-6 Supplementation of Infants: Biochemistry, Visual Development and

Growth", Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology and Medicine, American Heart Association, Dallas, Texas, April 17, 1994

18. "Dietary Arachidonic Acid Status in Infants: Effects of Dietary Arachidonate, Eicosapentaenoate and Docosahexaenoate", Symposium: The Biological Effects of Dietary Arachidonic Acid,


21

American Institute of Nutrition/Society for International Research, Atlanta, Georgia, April 11, 1995

19. "Preterm Infants Fed Formula Supplemented With Marine Oil DHA Compared With Controls Fed Only Linolenic Acid Have a Shorter Look Duration", American Oil Chemists'

Society Annual Meeting, San Antonio, Texas, May 11, 1995 20. "Neurodevelopmental Effects of N-3 LCPUFA", University of Colorado, Fort Collins, Colorado July 28, 1995 21. "Effect of LCPUFA on Visual and Cognitive Function", 40th Annual Nutrition and Food Science

Management Seminar, Austin, Texas, March 28, 1997 22. LCPUFA and Infant Development, Symposium on Function of N-3 Fatty Acids American Dietetics Association Annual Meeting, Boston, MA, October 30, 1997 23. Breastfeeding and the DHA Controversy, Plenary Lecture, American Academy of Pediatrics

Annual Meeting, San Francisco, CA, October 19, 1998 24. Long Chain Polyunsaturated Fatty Acids and Infant Development, Neonatal Nutrition Seminar

American Academy of Pediatrics Annual Meeting, San Francisco, CA, October 20, 1998 25. Neonatal Nutrition (Panelist with Dr. Robert Hall and Dr. Larry Gartner in taped interview)

American Academy of Pediatrics –Pediatric Update (CME series), Editor-in-Chief, Kurt Metzl, M.D., UMKC, School of Medicine, Taped in San Francisco, CA, October 20, 1998

26. Carlson SE: DHA and pregnancy outcomes in Applying Emerging Science: Targeting DHA for improvement of maternal and infant health, ADA Food and Nutrition Conference and Exhibition, Denver, CO, October 19, 2000.

27. Carlson SE. Dietary phospholipids and reduction of necrotizing enterocolitis: Plausible mechanisms. American Oil Chemists’ Society, Annual Meeting, Minneapolis, MN, May 14, 2001.

28. Carlson SE: Update on long chain fatty acids for infants and in maternal/fetal health (2 lectures), Leadership, Education and Training Program in Maternal and Child Health Nutrition, Univ. of Minnesota, May 2002.

29. Carlson SE: Dietary fatty acids and the brain. Department of Endocrinology, Univ. of Indiana/Purdue University Indianapolis (IUPUI), Indianapolis, IN, Nov. 18, 2002

30. Carlson SE. Human milk as a model for infant formula. Bristol-Myers Squibb/Mead Johnson Colloquiium, New Harmony, IN, June 2003.

31. Carlson SE. DHA supplementation and pregnancy outcome. Maternal Fetal Medicine Nutrition Interest Group, San Francisco, CA, Feb. 2003

32. Carlson SE. DHA and ARA Supplementation of Infant Formula and Implications for Infant Development. Pediatric Grand Rounds – KUMC, March 2002, Blank Children’s Hospital, Des Moines, IA, Ocotober 2002

33. Carlson SE. Ibid. Pediatric Grand Rounds, Children’s Hospital, Dayton, OH, Mar 2003 34. Carlson SE. Ibid. Pediatric Grand Rounds, LeBonheur Children’s Hospital, Memphis, TN,

August 2003 35. Carlson SE. Ibid. Masters of Pediatrics, Ft. Lauderdale, FL, Jan. 29, 2004 36. Carlson SE. Ibid. Florida Dietetic Association, West Palm Beach, FL, July 12, 2004 37. Carlson SE. Overview of Omega-3 Fatty Acids in Maternal and Infant Development. Invited

presentation to the American Dietetic Association, Anaheim, CA, October 3, 2004. 38. Carlson SE. DHA for Mothers and Babies. Invited lecture for Society for Pediatric Research

Workshop, April 29, 2006. 39. Carlson SE. Maternal and Infant DHA Nutrition: Impact on Infant Development. Indiana Dietetic

Association Annual Meeting, October 25-26, 2007. 40. Carlson SE. Polyunsaturated Fatty Acids and Development of Term and Preterm Infants.

American Dietetic Association 2008 Pediatric Nutrition Symposium, Building Blocks for Pediatric Practice, Minneapolis, MN, April 9-11, 2008


22

41. Carlson SE. Maternal DHA Supplementation: What is the evidence it is needed? Experimental Biology Symposium on Maternal Nutrient Supplementation, San Diego, CA, April 2008.

42. Carlson SE. Lipids and Infant Development, American Oil Chemists’ Society Invited Symposium, Phoenix, AZ, May 18, 2010

43. Carlson SE. Nutrition for Preterm Infants: A Research Agenda, Children’s National Medical Center, Washington, DC and University of MD, Newborn Practice group, Baltiimore, MD, September 22, 2010.

44. Carlson SE. Fatty acids and the fetus and newborn, Newborn Nutrition Conference, University of Minnesota, Minneapolis, MN, October 7, 2010

45. Carlson SE. Ramifications of insufficient DHA: evidence from studies during pregnancy and infancy. American Association of Physical Anthropologists Annual Meeting, Minneapolis, MN, April 15, 2011.

46. Carlson SE, et al. (Presented by Dr. Jo Wick): Infant formula with DHA reduces incidence of allergy-related illnesses during the first year of life. Pediatric Academic Societies annual meeting, Washington, DC, May 5, 2013

47. Carlson SE. Is DHA an essential nutrient for brain? National Lipid Association annual meeting, Las Vegas, Nevada, May 31, 2013.

48. Carlson SE. DHA and Developmental Programming. Department of Physiology, KUMC., Feb. 10, 2014.

49. Carlson SE. DHA and Developmental Programming. Department of Food Science and Nutriion, Iowa State University, Feb. 12, 2014.

50. Carlson SE. DHA and Developmental Programming. Pediatric Grand Rounds, KUMC, March 21, 2014.

51. Carlson SE. Healthy Fat Consumption Across All Life Stages – the US Experience, Neuroscience Program seminar series, University of Tennessee, Memphis, TN, October 20, 2014.

52. Carlson SE. Essential Fatty Acid Role in Brain Development. Pediatric Nutrition Conference sponsored by Integrative Medicine, Univ. of Kansas Medical Center, Nov. 14, 2014.

International (not industry sponsored): 1. "Protein Energy Requirements of Term and Preterm Infants", Second International Symposium

on Infant Nutrition and Development of the Gastrointestinal Tract, Niagara Falls, Ontario, Canada, June 21-25, 1982

2. "Polyunsaturated Fatty Acids in Infant Nutrition", "Essentiality of Omega 3 Fatty Acids" (Panel) Dietary Omega 3 and Omega 6 Fatty Acids: Biological Effects and Nutritional Essentiality Advanced Research Workshop sponsored by NATO, International Life Sciences Institute Research Foundation and the Nutrition Foundation of Italy,

Belgirate, Italy, June 20-23, 1988 3. Co-Chairman with Norman Salem: "Growth and Development in Infants" Second International

Conference on the Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, Washington, D.C., March 20, 1990

4. "Essentiality of Omega-3 Fatty Acids in Growth and Development of Infants", Second International Conference on the Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, Washington, D.C., March 1990 5. "N-3 Supplementation of the Very Small Premature Infant: Accumulation and Function" (Plenary

Lecture), Third Joint Meeting of the American and European Societies for Pediatric Gastroenterology and Nutrition, Amsterdam, Netherlands, May 24, 1990


23

6. "Growth and Development of Very Low Birth Weight Infants in Relation to n-3 and n-6 Essential Fatty Acid Status", Third International Congress on Essential Fatty Acids and Eicosanoids, Adelaide, South Australia, March 1-5, 1992

7. "Essential Fatty Acids in Neonatal Development", First Pacific Rim International Symposium on Fatty Acids: Evolution in Relation to Neurobiology, 35th Annual Meeting of the Canadian Federation of Biological Societies, Victoria, Canada, June 18, 1992

8. "Distribution and Function of Omega-3 Fatty Acids in Fetal and Adult Tissues" Symposium on Omega-3 Fatty Acids: Metabolism and Biological Effects, Oslo, Norway September 16, 1992 9. "The Effect of Marine Oil-Supplemented Formulas With and Without Eicosapentaenoic Acid on the n-3 and n-6 Fatty Acid Status and Growth of Premature Infants", Fifth International Meeting of The Society for Research on Polyunsaturated Fatty Acids, Tokyo, Japan, November 1992 10. "Growth and Development of Premature Infants in Relation to n-3 and n-6 Fatty Acid Status", First International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland, July 1, 1993 11. "Polyunsaturated Fatty Acid Status and Later Outcome of Preterm Infants" Plenary Lecture, Annual Meeting of the Dutch Paediatric Association Amsterdam, The Netherlands, November 2, 1994 12. "Long Chain Polyunsaturated Fatty Acids and Infant Growth and Development" University of Guelph Department of Nutrition, Guelph, Ontario, Canada, March 22, 1996 13. "EFA Metabolism in Infant Nutrition", Tygerberg Hospital Department of Paediatrics Capetown, South Africa, March 27, 1996 14. Workshop on Fatty Acids in Health, University of Stellenbosch, Stellenbosch, South Africa March 31, 1996 15. "Essential Fatty Acid Metabolites in Growth and Development", South African Nutrition

Congress, Stellenbosch, South Africa, April 3, 1996 16. "Effects of DHA Supplementation on Visual Acuity and Visual Attention of Preterm Infants" Symposium on Infant Nutrition: Dietary Effects on the Development of Vision, Cognition and

Language, International Conference on Infant Studies, Providence, Rhode Island, April 19, 1996 17. "Significance of Long Chain Fatty Acids in Infant Nutrition" Symposium on Infant Nutrition

Celebrating the 50th Anniversary of the National Nutrition Council of Norway, Oslo, Norway August 28, 1996 18. "N-3 LCPUFA and Infant Neural Development", University of Limburg, Maastricht, The

Netherlands, June 14, 1996 19. "Methodology of Neurodevelopmental Assessment", International Conference on Highly

Unsaturated Fatty Acids in Nutrition and Disease Prevention, Barcelona, Spain, November 6, 1996

20. "N-3 and N-6 Supplementation of Infants", The Role of LCPUFA in Neonatal Nutrition Florence, Italy, November 14, 1996 21. LCPUFAs and Early Development of Infants, International Symposium on Advances in Infant

Feeding: Human Milk and Formula, Baveno, Italy, March 20, 1998 22. Infant Development in Relation to LCPUFA Status, Pediatrics Sumposium, Ancona, Italy, May 20-22, 1999 23. LCPUFA Supplementation of Preterm Infants: Neural Influences in Three Trials 23rd World Congress and Exhibiton of the International Society for Fat Research Brighton, England, October 3-7, 1999 24. DHA and Pregnancy, Symposium on Omega 3 fatty acids in Perinatal Medicine, Oslo, Norway,

18th European Congress of Perinatal Medicine, June 19,, 2002.


24

24. Increasing docosahexaenoic acid intake during pregnancy increases length of gestation. International AOCS meeting, Taipei, Taiwan, September 2002.

24. Phospholipids in infant nutrition: Plausible and researchable roles in gut function suggested by recent findings. 8th International Lecithin and Phospholipid Society meeting, Vienna, Austria, September 2002

25. Carlson SE. The role of LCPUFA (DHA+ARA) in infant development., Japanese Society of Nutrition and Food Science, Fukuoka, Japan, May 2003

26. Carlson SE. Maternal long chain fatty acid metabolism and nutrition: Influences on pregnancy outcome and neonatal development. Mother and Infant Conference, Montreal, Canada, June 2003.

27. Carlson SE. Increased DHA intake during the last trimester of pregnancy may extend the duration of gestation and enhance foetal growth. Possible mechanisms underlying behavioral effects of DHA and AA during development. Mother and Newborn Present and Future, Milan, Italy, December 11-12, 2003.

28. Carlson SE. Invited expert for the EU supported PERLIP Consensus Conference:on “Dietary fat intake during the perinatal period”, September 11-14, 2005, Wildbad Kreuth, Bavaria, Germany (declined because of time conflict).

29. Carlson SE. Organizer for maternal and infant section of the International Society for Study of Fatty Acids and Lipids, Cairns, Australia, July 22-29, 2006.

30. Carlson SE. Omega-3s in Pregnancy and Infancy. 3rd Workshop on Omega-3 Fatty Acids in Functional Foods, Shanghai, China, November 8-9, 2007.

31. Carlson SE. “Long-chain polyunsaturated fatty acids and infant and child development.” Amsterdam, The Netherlands, June 3, 2008.

32. Carlson SE. “DHA in Infant Formulas” invited presentation for A Celebration of DHA to honor Dr. Michael Crawford’s 30 years of research on DHA, London, UK, May 27, 2010

33. Carlson SE: Dietary cholesterol for infants – it’s in human milk. Should it be in infant formula? ISSFAL 2010 Satellite Symposium – New Frontiers in Infant Feeding, Maastricht, The Netherlands, May 29, 2010

34. Carlson SE. Lipids and early brain function and development, University of Copenhagen, Denmark, August 26, 2010.

35. Carlson SE. (Keynote lecture): Long chain PUFA and infant and child development. EuroFed Lipid Congress, Munich, Germany, November 23, 2010.

36. Carlson SE. Early determinants of development: a lipid perspective and N-3 fatty acids and cognitive and visual acuity development: Methodologic and conceptual considerations. 3rd International Symposium of Neonatal Nutrition. Cartagena, Colombia, February 25 and 26, 2011.

37. Carlson SE. Pregnancy and LCPUFA. ISSFAL 2012, Vancouver, BC, May 26-30, 2012. 38. Carlson SE. Pediatric Society of Australia and New Zealand, April 16 and 17, 2013. 39. Carlson SE. A randomized trial of DHA supplementation and pregnancy outcome. 8th Asia

Pacific Conference on Clinical Nutrition, Tokyo, June 9, 2013. 40. Carlson SE. DHA and Cognition. Barcelona, Spain, Jan. 30, 2014 41. Carlson SE. DHA and Pregnancy and DHA and Development, 2 lectures, Ob Gyn Conference,

Hong Kong, May 24, 2014. 42. Carlson SE. DHA in Pregnancy and Childhood (2 lectures), Warsaw, Poland, October 8,9 2014. 43. Carlson SE et al. Maternal DHA Supplementation and Body Composition at Age 5 years.

Presented at DOHaD in Cape Town, November 2015. 44. Carlson SE. Omega-3 fatty acids and perinatal health, GOED (an omega-3 fatty acid trade

organization) conference, Tenerife, Canary Islands, February 3, 2016. 45. Carlson SE. Maternal DHA supplementation and blood pressure in 4-6 year old children.

ISSFAL 2016, Stellenbosch, South Africa, September 6, 2016.


25

46. Carlson SE. Is ARA and Essential Nutrient for Infant Development. ISSFAL 2016, Stellenbosch, South Africa, September 5, 2016

National and International (sponsored by industry): 1. "Impact on Infant Feeding on Blood and Membrane Lipids", Seminar on Fats and Cholesterol in

Infants and Children, Wyeth Laboratories, Helsinki, Finland, June 28, 1984 2. "Impact of Infant Feeding on Blood Lipids", Video Conference: Primary Prevention of

Atherosclerosis in Childhood - The Role of Lipids. Impact on Infant Feeding on Blood and Membrane Lipids, Wyeth Laboratories, New York, New York, May 27-28, 1985

3. "Breastfeeding and Lipid Metabolism", 91st Ross Conference, The Breast-fed Infant: A Model for Performance, Carefree, Arizona, October 27-30, 1985

4. "Accumulation and Possible Function of Highly Polyunsaturated Fatty Acids in Membranes During Development", "Accumulation of Highly Polyunsaturated Fatty Acids in Cell. Membranes of the Preterm Infant: The Role of Diet", 31st Perinatal and Developmental Symposium, Mead Johnson Symposium on Infant Nutrition, Palm Desert, California. November 15-19, 1987

5. "Omega-3 Fatty Acids and Infant Nutrition", Campbell Institute for Research and Technology, Camden, New Jersey, January 26, 1989

6. "Long Chain Fatty Acids and Infant Nutrition", Advanced Research Workshop on Essential Fatty Acids and Infant Nutrition (Sponsored by Milupa), Athens, Greece, May 26-27, 1989

7. "Plasma Arachidonic Acid and Growth in Preterm Infants", Milupa Symposium on Recent Advances in Infant Feeding, Leidschendam, Netherlands, May 27, 1990

8. "The Role of PUFAs in Infant Nutrition", Hoffman-La Roche PUFA Conference, Ashbourne, Derbeyshire, England, November 13, 1990

9. "Influence of Corn, Soy and Marine Oils in Premature Formulas With Particular Reference to Arachidonic and Docosahexaenoic Acid, Growth and Development", Mead Johnson Symposium on Lipids in Infant Nutrition, Chatham, Massachusetts, August 30, 1991

10. "Lipid Requirements of Very Low Birth Weight Infants for Optimal Growth and Development". Second Dobbing Conference on Lipids, Learning and the Brain: Fats in Infant Formula (Sponsored by Ross Laboratories), Adelaide, Australia, March 7-9, 1992

11. "Long Chain Fatty Acids and Visual and Cognitive Development of Preterm Infants", Milupa Symposium, Nottingham, England, September 2, 1993

12. "Long Chain Fatty Acids and Visual and Cognitive Development of Preterm Infants", Milupa Symposium on Progress in Premature and Infant Feeding Center for Studies on Infant Nutrition/Argentine Pediatric Society, Buenos Aires and Cordoba, Argentina, September 22 and 24, 1993

13. "DHA and Infant Nutrition", Pfizer Research Nutraceutical Symposium, Mystic, Connecticut, November 16, 1993

14. "Assessment of Infants Receiving Marine Oil-Supplemented Formulas", Eighth Wyeth-Ayerst Nutritional Seminar on New Insights Into Lipids in Infant Nutrition, Cerromar Beach, Puerto Rico, December 2-5, 1993

15. "Do Current Feeding Practices Meet the In-Hospital Needs of Preterm Infants for EFA?" 106th Ross conference on Pediatric Research, Colorado Springs, Colorado, August 18-20,

1995 16. "Effects of Formulas With and Without DHA on First-Year Growth, Visual Grating Acuity, and

Neurodevelopmental Outcomes of Preterm Infants", 106th Ross Conference on Pediatric Research, Colorado Springs, Colorado, August 18-20, 1995

17. "N-3 and N-6 Supplementation of Term Infants", 10th Nutricia Symposium on Recent Developments in Infant Nutrition, Scheveningen, The Hague, Nov 29 to Dec 2, 1995


26

18. "The Role of LCPUFAs in Visual and Cognitive Development", SODILAC, Paris, France December 3, 1996 19. “ Polyunsaturated Fatty Acids and Infant Development”, Long Term Effects of Fetal and Early

Childhood Events on Later Development and Disease Risk, Milupa Scientific Symposium Bremen, Northern Germany, October 15-17, 1999 20. “Infant LCP Trials: Visual and Other Neurodevelopmental Outcomes”, LCP and Infant Nutrition –

Can we improve current practice? Nutricia-Milupa Scientific Symposium, Birmingham, UK, December 1, 2001.

21. Carlson SE. Human milk as a model for infant formula. Bristol-Myers Squibb/Mead Johnson Colloquiium, New Harmony, IN, June 2003.

22. Carlson SE. Optimizing maternal and Infant DHA intake. Presented at Mead Johnson Speakers Symposium, Henderson, NE, June 11, 2005.

23. Carlson SE. “Homeward Bound: Postdischarge nutrition of preterm infants.” Nourishing the Neonate Conference, Orange County, CA, September 20-21, 2007.

24. Carlson SE. Ibid, Dallas, TX, October 5-6., 2008 25. Carlson SE. “Omega-3 PUFA and Brain Development, “ Wyeth Global Nutrition Advisory Board

Meeting, Madison, NJ, November 12-14, 2008. 26. Carlson SE. EFSA Consultation, Mead Johnson Nutrition, Brussels, Belgium, January 5, 2010. 27. Carlson SE. Nutrition and brain development. Guangzhou and Beijing, China, June 8 and Jun

12, 2012. 28. Carlson SE, Lauritzen L and Smuts CM. ISSFAL Workshop on Maternal, Infant and Child

Nutrition session on pregnancy, preterm and term infants and children. Vancouver, BC, May 31, 2012.

29. Carlson SE. DHA and child health, Hong Kong, April 23, 2013. 30. Carlson SE. Three talks based on references 81, 82 and 83 in Hong Kong for Wyeth. August 5-

7, 2013. 31. Carlson SE. DHA and child health. Buenos Aires, Argentina, May 10, 2013.(rescheduled for

August 29, 2013). 32. Carlson SE. Two talks on DHA in child health and pregnancy. Warsaw, Poland, September

2013 33. Carlson SE. DHA in Pregnancy and Childhood, Glaxo Smith Klein, London, UK, June 26, 2014. 34. Carlson SE. DHA and Developmental Programming, Rome, Humana GMBH (European Dairy

Cooperative), Italy, September 16, 2014. 35. Carlson SE. Cognitive results from the DIAMOND trial. April 21 and 22, 2015. Manila,

Philippines (Mead Johnson Nutrition). 36. Carlson SE. LCPUFA in Development. May 5, 2015. Amsterdam, The Netherlands, DSM

(DSM). 37. Carlson SE. LCPUFA in Development, May 15, 2015. Washington, DC (DSM). 38. Carlson SE. LCPUFA: Cognition, vision and beyond. Presented for Danone/Nutricia in Delhi,

Chennai, Kolkata, Hyderabad and Mumbai, March 21-25, 2017.

University/Government/Foundation/Institutes: 1. "Significance of Carnitine in Infant Diets." A report prepared for the Committee on Nutrition of

the American Academy of Pediatrics and the Food and Drug Administration following a conference held in Tampa, Florida, May 1979

2. "Docosahexaenoic Acid Status of Preterm Infants: Biochemical Effects of Nutritional Manipulation", Lotte Arnrich Lecture, Iowa State University, Ames, Iowa, April 11, 1986

3. "Lipid Nutrition and Visual Acuity", First Joint Symposium on Nutrition and Aging of the


27

Nervous System, The Institute for Developmental Neuroscience and Aging and The Institute for Research on Senescence, The University of Texas Medical Branch at Galveston, Galveston, Texas, October 25, 1990

4. "Visual Acuity, Growth, and Cognition in Preterm Infants: Relationship to n-3 and n-6 Fatty Acid Status", Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, February 21, 1991

5. Invited Speaker and Panelist: "n-3 Fatty Acid Requirements of Infants", Food Directorate Symposium, Bureau of Nutritional Sciences, Ottawa, Ontario, Canada, June 21, 1991

6. Invited Presentation: "Long Chain Fatty Acids and Visual Function", Workshop "Abnormalities in Lipid Metabolism in Retinitis Pigmentosa", Retinitis Pigmentosa Foundation, The Woodlands, Texas, March 20, 1993

7. .Seminar: "Effect of Early Feeding on Later Outcomes in Preterm Neonates", Pew National Nutrition Foundation, Center for Nutritional Sciences, University of Florida Gainesville, Florida, April 5, 1993

8. Speaker and Discussant: Fish Oil Test Materials Program Advisory Committee, National Institutes of Health and Department of Commerce, Bethesda, Maryland, May 12, 1994

9. "Fatty Acids and Neural Function", New Approaches to Define Nutrient Requirements USDA, University of California and UC Davis, Department of Clinical Nutrition, San Francisco,

California, July 14-15, 1994 17. Critical Review on Trans Fatty Acids and Early Development: Expert Panel, International Life

Sciences Institute,1995-1996 18. Consensus Meeting on Long Chain Polyunsaturated Fatty Acids and Perinatal Development,

Child Health Foundation, Munich, Germany, July 18-21, 1999 19. “Dietary Long Chain Fatty Acids and Visual Development in Infants”, How Nutrition Affects

Cognition: Implications for Feeding Infants and Children, 29th Annual Current Issues in Nutrition. A satellite videoconference originating from Iowa State University, .April 27, 2000.

20. CHERAB Conference: The first Scientific Conference on Therapy for Verbal Apraxia/Dyspraxia, Scientific Panel and presenter, July 23-24, 2001.

21. Carlson SE. Behavioral and Molecular Effects of Modest Reductions in Brain DHA for Brain Uptake and Utilization of Fatty Acids (NIH conference), Bethesda, MD, October 20, 2004

22. Carlson SE. DHA and ARA Supplementation of Infant Formula and Implications for Infant Development. Univ. of Maryland, Baltimore, MD, Nov. 12, 2004

23. Carlson SE. Committee on Nutrient Relationships in Seafood: Balancing Benefits and Risks, Institute of Medicine, Food and Nutrition Board, The National Academies, December 2004 to present (work to be completed fall 2006).

24. Carlson SE. Omega-3 fatty acids and visual and cognitive function. Columbia University Symposium, May 22, 2005.

25. Carlson SE. Health benefits of n-3 fatty acids for pregnant and lactating women and infants. Workshop on Developing Functional Foods with Omega-3 Fatty Acids at Univ. of Massachussetts, Amherst, MA, June 9, 2005

26. Carlson SE. Invited presentation on health benefits of omega-3 fatty acids for the 2005 National Forum on Contaminants in Fish sponsored by the U.S. Environmental Protection Agency, Sept. 18-21, 2005.

27. Carlson SE. Fatty Acids and Neuronal Development: The DHA Story. Masters of Pediatrics Leadership Conference, Bal Harbour, Fl, January 25-30, 2006

28. Carlson SE. Invited presentation on health benefits of omega-3 fatty acids for the 2006 annual meeting of AAAS, St. Louis, MO, Feb 17, 2006.

29. External consultant for NIEHS panel in Raleigh, NC speaking on quality of the evidence for benefits of DHA. March 8-9, 2006.


28

30. Carlson SE. Invited presentation on health benefits of omega-3 fatty acids for the 29th Annual Seafood Science and Technology Conference in San Antonio, TX – November 13-16, 2006.

31. Carlson SE. Heath Benefits of Seafood – Women, Infants and Children. Benefits and Risks Associated with Seafood and Aquaculture Consumption, Florida Sea Grant – University of Florida/IFAS In-Service Training Program, Gainsville, FL, March 26-27, 2007.

32. Expert panelist for the LSRO Nutrition Formula for Preterm Infants Post-hospital discharge (report completed in 2007).

33. Carlson SE. EPA/DHA and Brain Development, What You Eat. What You Do. Who You Are. Tufts University Friedman School of Nutrition Science and Policy, October 29-31, 2007

34. Carlson SE. Early determinants of risk for suboptimal neurodevelopment in relation to specific time windows such as pregnancy and infancy. ILSI North American: Food, Nutrition and Safety Program, Early Nutrition Subcommittee Workshop, Washington, DC, July 8-9, 2008.

35. Carlson SE. Intrauterine maternal to fetal fatty acid transfer. Mathilde Institute invited lecture, Napa Valley Lodge, Yountville, CA, September 23, 2010

36. Carlson SE. Clinical overview of effects of dietary LCPUFA during the perinatal period on infant health. 77th Nestle Nutrition Institute Workshop “the importance of immunonutrition”. Panama, October 28th – November 1, 2012

37. Carlson SE. Overview of effects of dietary LCPUFA during the perinatal period. University of Cincinnati, Dept. of Nutrition, Rosevear Lecture, Nov. 16, 2012.

38. Carlson SE. Early and Late Effects of Dietary DHA for Mothers and Newborns. Department of Kinesiology, University of Waterloo, Waterloo, Canada, Sept. 13, 2013

39. Carlson SE. DHA and Infant/Child Development. Early Nutrition Academy meeting. Singapore, November 16, 2013.

40. Carlson SE. DHA and Child Development. 8th World Congress on the Developmental Origins of Health and Disease (DOHaD), November 17, 2013 (lecture given to replace Dr. Stewart Forsyth who had a family emergency).

41. Carlson SE. Evidence that DHA is an Essential Nutrient for Human Development, National Institue on Aging, John Hopkins Bayview, Baltimore, MD, March 18, 2014.

42. Carlson SE. Pre B WG-1 meeting to set agenda for nutrient intake by preterm infants, Houston, TX, July 31-Aug 1, 2015.

43. Carlson SE, Kerling EH, Thodosoff JM, Hidaka BH, Hull HR, Colombo, J. Maternal DHA supplementation and body composition at age 5 years. Capetown, South Africa, November 7-12, 2015.

44. Member of the Institute of Food Technology delegation to CODEX, (participated in the US delegation led by the FDA), Bad Soden, Germany, November 23-24, 2015.

45. Carlson SE. A nutritionist’s perspective on behavioral assessment. Presented at the Nestle Nutrition Institute meeting in Dubai, UAE, March 29, 2017

TEACHING: Undergraduate courses Human Nutrition (3 credit), University of South Florida, College of Nursing, 1982 Graduate and Postgraduate DN 817 Seminar in Dietetics and Nutrition, Summer 2008; Spring 2009; Summer 2009, 2010 DN 817 Seminar in Dietetics and Nutrition, Summer 2008-2010, Fall 2009 DN 819: Seminar in Dietetics and Nutrition: Literature review Fall 2015 DN 895 Advanced Macronutrient Nutrition and Integrated Metabolism, Fall 2010


29

DN 896, Advanced Micronutrient Nutrition, Spring 2010, Spring 2011 DN 980: Nutrigenomics and Nutrigenetics in Health and Disease, Fall 2011, Summer 2014, Summer 2015, Summer 2016 DN 890: Research in nutrition (most semesters) DN 899: Thesis research in nutrition (most semesters) DN 901: PhD Seminar in Nutrition, Fall 2010 - present DN 900: Techniques in nutrition research, Summer 2010 – Present DN 990: Dissertation research: Marlies Ozias, Susan Scholtz, Shengqi Li, Brandon Hidaka DN 999: Dissertation: Marlies Ozias, Susan Scholtz, Shengqi Li, Brandon Hidaka, Leigh Wagner Medical Students, 1978-1997, 8-16 hours/year (Medical Student Golden Apple Award for Teaching, University of Tennessee, Memphis, College of Medicine, 1992); Nutrition in Medical Physiology, 2000- present, University of Kansas Medical Center and coordinator of nutrition in the Medicine, Pediatric Clerkship 1999 to present, Obstetrics and Gynecology, Aging Clerkships (M-3), University of Kansas Medical Center. American Society of Clinical Nutrition/American Medical Student Association Clinical Nutrition Internship Mentor: Summer 2001 for Lucas Meek, Charlotte Ransom, and Kristin Wismer; Summer 2002 for Trevor Gaskill; Summer 2003 for Leslie Ablard; Summer 2005 for Candace Rose (~10 are awarded nationally each year); Cindy Vu (Summer 2014). Research Mentor: Summer 2001 for Lucas Meek and Kristin Wismer (M-2s); Summer 2002 for Trevor Gaskill., Steven Kosa, Socheata Un; Summer 2003 for Mathew Humpert; Paul St Romain Summer 2008 Two students have won first place in the Medical Student Research Award: Trevor Gaskill (2003) and Paul St Romain (2008). Dr. Jinping Zhao, Sponsored as Visiting Scientist from China, May 2001 to October 2001. Yearly lectures to Pediatric Residents and Neonatology Fellows, 1986-1997 (UT, Memphis) and 2000-present (KUMC) Pediatric Grand Rounds, Newborn Center Research Seminars, Journal Club, 1978-1997 University-sponsored inservice and outreach education (1983-1986): Breast Feeding, Infant Nutrition, Formula Composition, Maternal Nutrition and Pregnancy Outcome CME Courses (listed separately) under Visiting Professorships/Invited Lectures) University of Memphis (formerly Memphis State University), Memphis, TN Clinical Rotation and didactic lectures in Nutrition of the Preterm Infant for M.S., R.D. candidates: NICU 8 students (2 weeks) 1988-1992 From 1993 – 1997, M.S., R.D. students did their clinical training with our NICU nutritionists and I

participated as a lecturer. . University of Memphis -The University of Tennessee, Memphis, Internship for M.S., R.D.: Clinical Service Supervisor in the Neonatal Intensive Care Unit 3 students (1 month) 1988-1992 N598 Supervised study, UMKC (1997-1999) and KUMC (2002)

Maithe Fowler: Nutrition, the immune system and HIV disease, Fall 97 Richard Downing: Mechanism of action of drugs provided for clinical depression, Winter 98

Joyce Headon: Supplementation of pregnant women with LCPUFA, Summer 98 Pam Kepus: Supplementation of pregnant women with LCPUFA, Winter 99 Joyce Headon: Nutritional correlates of LBW and prematurity, Winter 99

Pam Kepus: Pregnant women’s recollection and understanding of recommendations from health professionals, Summer 99


30

Candace Rose: Nutrition for preterm infants, Fall 2002 Monique Fee: Nutrition for preterm infants, Fall 2006 N555 Quantitative Methods in Nursing Research (taught with Dr. Steve Krantz), Winter 99 ------ Physiology/Pathophysiology of the Neonate, Guest lecturer on the Gastrointestinal System and

Metabolic and Endocrine Conditions (3 hrs) N490C Nutrition in Health and Disease, 3 credits, Summer 99 KUMC, Nutrition lectures to Pediatric residents, 2000 (3 hrs) KUMC, Guest lectures on nutrition in Critical Care Nursing and Research Methods, 2000 (2 hrs);

lectured yearly since in Research Methods KUMC, DN 896 Spring 2010, 2011; DN 895, Fall 2010, DN 980, Fall 2011; DN 901 Spring, 2010, 2012,

2013; Fall 2010, 2011, 2012; Lectured in DN 895 Fall 2011, 2012. KUMC Summer 2014 DN 980, Spring and Fall 2014 DN 901, Techniques in Nutrition Research (as

needed throughout the year) DN 900. FELLOWS/GRADUATE STUDENTS TRAINED: Master of Science (directed MS project or thesis* research) 1982 Nutrition and Food Science Jane Carver Putnam* Florida State University 1986 Nursing Edith E. Anderson University of Mississippi Medical Center 1989 Nutrition Diane E. Free* Memphis State University 1990 Nutrition Michelle R. Smith* Memphis State University 1991 Nutrition Lisa C. Denny* Memphis State University 1992 Nutrition Shannon Maxwell* Memphis State University 1996 Nutrition Tracy Sargent* The University of Memphis (formerly MSU) 1997 Nutrition Wendy E. Donley* The University of Memphis 2000 The University of Kansas Medical Center Jennifer Colling, RD* Dietetics and Nutrition 2001 The University of Kansas Medical Center Amanda Schraegle, RD* Dietetics and Nutrition 2001 The University of Kansas Medical Center Miranda Gaskin, RD* Dietetics and Nutrition 2002 The University of Kansas Medical Center Jamie Wilkins, RD* Dietetics and Nutrition 2002 The University of Kansas Medical Center Amy Marra, RD* Dietetics and Nutrition 2002 The University of Kansas Medical Center Diana Rodenberg, RD* Dietetics and Nutrition (nonthesis) 2004 The University of Kansas Medical Center Kasey Carter, RD* Dietetics and Nutrition (nonthesis) 2004 The University of Kansas Medical Center Candice Jorgensen* Danielle Mercer*


31

2005 The University of Kansas Medical Center Stella Vergara* 2008 The University of Kansas Medical Center Bhavana Gottipati* Elizabeth Kerling* 2009 The University of Kansas Medical Center Lara Kunz, RD* Susan Kary* Nicole Kreber* 2010 The University of Kansas Medical Center Shengqi Li* Katherine Harvey* Leigh Wagner 2011 The University of Kansas Medical Center Amanda Foiles* Sarah Douglas* Sarah Scroggs* Ka Ian Chen* Sara Moukarzel* 2012 The University of Kansas Medical Center Deanna Mortimer* Claire Cody* Danielle Atwood* Lindsey Currie* Mallory Bratton* 2013 The University of Kansas Medical Center Erin Plumberg* Elizabeth Rogg* Loran Park* 2014 The University of Kansas Medical Center Abbie Lowe Lucy Pappas* Sara Grimm Karla Wessling* 2015 Taranjeet Singh 2016 Jamie Hilton* Emily Hastings* Doctor of Philosophy Dissertation Committees (*directed research) 1992 Physiology Bobbie L. Henken The University of Tennessee, Memphis 1994 Nursing Rose Nealis* University of Texas, Austin 1995 Physiology Ali Banan The University of Tennessee, Memphis 1996 Nutrition, Department of Human Biology Margret Foreman-van Drongelen University of Maastricht, The Netherlands (External examiner) 2000 University of Maastricht, The Netherlands Suzie Judessa Otto (External examiner) 2002 Institute for Nutrition Research, University of Oslo Ingid B. Helland (External examiner) 2003 University of Maastricht, The Netherlands Renate H.M. de Groot (external examiner) 2007 Institute for Nutrition Research, University of Oslo Christine Henriksen (External examiner) 2008 University of Amsterdam, The Netherlands Manon van Eijsden


32

(External examiner) 2009 University of Iceland, Reykjavik Anna Ragna Magnusardottir (External examiner) 2012 Medical Nutrition Science, Univ. of KS Med Ctr. Susan Scholtz* 2013 Medical Nutrition Science, Univ. of KS Med Ctr Marlies Ozias* Shengqi Li 2015 Brandon Hidaka (MD, PhD student)* Fellows and Assistant Professors Trained/Mentored 1984-1986 Frank Liu, PhD, University of Mississippi Medical Center, Jackson, MS 1989 –1991 Tara Burnette, M.D., Neonatology, Univ. of Tennessee, Memphis, TN 1994 -1995 Sujatha Rajaram, Ph.D., Nutrition, Purdue University (Major Profesor: Connie Weaver) 1998 - 1999 Marius Smuts, Ph.D., Biochemistry, University of Stellenbosch 1996 (Major Professor: KJ Kirsten) 1998 - 2001 Minzhao Huang, Ph.D., Pharmaceutical Science, Nagoya City University (Major Professor: Harumi Okuyama, Ph.D.) 2002-2005 Shashi Kundurthi, Ph.D. 2004-2005 Cheryl Miller, Ph.D. (Res. Asst. Prof., Dept. of Dietetics and Nutrition) 2005-2008 Carol Cheatham, Ph.D. (Res. Asst. Prof. Dept. of Dietetics and Nutrition 2005- 2008 Ann McGrath Davis, Ph.D. (Dept. of Pediatrics), K21 Mentor 2006-2008 Andrea Charbonneau Ely, M.D. (Internal Medicine), K21 Mentor 2005-2008 Ann Manzardo, Ph.D. (Dept. of Psychiatry), Consultant for K21 project 2006-2008 Nicole Nollen, Ph.D. (Dept. of Preventive Medicine), primary mentor for BIRCWH award 2006 Asma Zaide, Ph.D. (Dept. of Pharmacology and Toxicology, Univ. of KS), CoNRE research mentor 2009-Present Director of KUMC BIRCWH Program (Biomedical Interdisciplinary Research Careers in Womens’ Health. Role in mentoring faculty scholars that include to date: Clifford Mason, PhD, OB-Gyn; Sarah Kewieg, PhD, KU Engineering; Christie Befort, PhD, Preventive Med; Kelly Bosak, PhD Nursing; Holly Hull, PhD Dietetics and Nutrition;

Jennifer Klemp, PhD Psychology; Lisa VanHoose, PhD, Physical Therapy; Harsh Pathak, PhD, Pathology

ABSTRACTS PRESENTED AND PUBLISHED (NATIONAL AND INTERNATIONAL) 1. Carlson SE, Arnrich L: Influence of meal pattern and dietary fat on 4-14C-cholesterol

metabolism in adult rats, presented before FASEB, Atlantic City, NJ, April 1975. Federation Proceedings 34:891(#3806) 1975.

2. Carlson SE, Mitchell AD, Goldfarb S: Sex-related differences in hepatic cholesterol and bile

acid metabolism, Poster presentation at Midwest AFCR, Chicago, IL, November 1977. Gastroenterology 73:17A, 1977.

3. Carlson SE, Mitchell AD, Goldfarb S: Regulation of hepatic HMG-CoA reductase activity (HMG) in response to sex hormones in adult rats, Poster presentation at FASEB, Dallas, TX, April 1979. Federation Proceedings 38:1252(#5416),1979. 4. Carlson SE, DeVoe PW, Barness LA: The effects of human milk and infant formulas on

circulating high density lipoprotein, Poster presentation at AAP/SPR, April 1981. Pediatric Research 15:528(#527), 1981.


33

5. Carlson SE, Barness LA: Protein and energy requirements of term and preterm infants,

presented before Second International Gastroenterology and Nutrition Meeting, Niagara Falls, Ontario, Canada, June 1982. Journal of Pediatric Gastroenterology and Nutrition 2:581-587, 1983.

6. Carlson SE, Ferguson MG, Rhodes PG: Effect of human milk and vegetable oil-containing

formulas on docosahexaenoic acid of preterm red cell membrane phospholipids, Poster presentation at the AAP/SPR, Washington, DC, May 1985. Pediatric Research 19:214A(#623), 1985.

7. Carlson SE, Palmer SM, Caldwell EI, Rhodes PG: Folate status and length of gestation, Poster

presentation at the American Society for Clinical Nutrition, Washington, DC, May 1985. American Journal of Clinical Nutrition 41:844, 1985.

8. Carlson SE, Rhodes PG: Effect of fish oil supplementation on docosahexaenoic acid content of

preterm red blood cell membrane phospholipid, Poster presentation at AAP/SPR, Washington, DC, April 1986. Pediatric Research 20:293A(#815), 1986.

9. Carlson SE, Rhodes PG, Rao V: Accumulation of docosahexaenoic and eicosapentaenoic

acids in plasma lipids following fish oil administration to preterm infants, Poster presentation at the American Society for Clinical Nutrition, Washington, DC, May 1986. American Journal of Clinical Nutrition 43:684, 1986.

46. Carlson SE, Cooke RJ, Werkman SH, Peeples JM, Tolley EA: Red blood cell

phosphatidylethanolamine docosahexaenoic acid is a predictor of visual acuity in preterm infants, presented before the Southern Society for Pediatric Research, New Orleans, LA, Feb. 2, 1989. Clinical Research 37(1):46A, 1989

11. Cooke RJ, Werkman SH, Watson D, Conner C, Carlson SE: Effect of type of protein on growth

and other parameters of nutritional status in the preterm infant, Poster presentation (R. Cooke) at the Southern Society for Pediatric Research, New Orleans, LA, Feb. 1, 1989. Clinical Research 37(1):46A, 1989.

12. Peeples J, Carlson S, Cooke R, Werkman S: Long term supplementation of preterm infants

with docosahexaenoate (DHA) and eicosapentaenoate (EPA): Effect of RBC phosphatidylethanolamine (PE) fatty acid composition, presented before FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), New Orleans, LA, March 22, 1989. FASEB Journal 3(4):A1056(#4822), 1989.

13. Carlson S, Cooke R, Werkman S, Peeples J: Docosahexaenoate (DHA) and

eicosapentaenoate (EPA) supplementation of preterm (PT) infants: Effects on phospholipid DHA and visual acuity, presented before FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), New Orleans, LA, March 22, 1989. FASEB Journal 3(4):A1056(#4823), 1989.

14. Carlson SE, Cooke RJ, Peeples JM, Werkman SH, Tolley EA: Docosahexaenoate (DHA) and

eicosapentaenoate (EPA) status of preterm infants: Relationship to visual acuity in n-3 supplemented and unsupplemented infants, presented before the Society for Pediatric Research, Washington, DC, May 4, 1989. Pediatric Research 25(4):285A(#1696), 1989.


34

15. Carlson SE, Peeples JM, Werkman SH, Cooke RJ: Vitamin A status of preterm infants following discharge, presented before the Southern Society for Pediatric Research, New Orleans, LA, Jan. 18, 1990. Clinical Research 38(1):44A, 1990.

16. Burnette TM, Carlson SE: Hypoxanthine metabolism and clinical outcome in the very low birth

weight infant, presented (T. Burnette) before the Southern Society for Pediatric Research, New Orleans, LA, Jan. 18, 1990. Clinical Research 38(1):62A, 1990.

17. Carlson SE, Peeples JM, Werkman SH, Cooke RJ, Wilson WM: Arachidonic acid (AA) in

plasma and red blood cell (RBC) phospholipids (PL) during followup of preterm infants: Occurrence, dietary determinants and functional relationships, presented before the II International Conference on the Health Effects of Omega-3 Polyunsaturated Fatty Acids in Seafoods, Washington, DC, March 1990.

18. Carlson SE, Werkman SH, Cooke RJ, Peeples JM, Tolley EA: Docosahexaenoate (DHA) and

eicosapentaenoate (EPA) status of preterm infants: Relationship to the Fagantest of Infant Intelligence and the Bayley Scale of Mental Development, presented before FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), Washington, DC, April 4, 1990. FASEB Journal 4(3):A1156(#5171), 1990.

19. Burnette TM, Carlson SE, Tolley EA: Plasma xanthine levels are elevated prior to clinical

necrotizing enterocolitis, presented (T. Burnette) before the Society for Pediatric Research, Anaheim, CA, May 10, 1990. Pediatric Research 27(4):101A(#594), 1990.

20. Gupta I, Carlson SE, Peeples JM, Korones SB, Sibai BM: A survey of the effects of antenatal

steroid administration upon plasma retinol and retinol binding protein in premature infants, presented (I. Gupta) before the Southern Society for Pediatric Research, New Orleans, LA, Jan. 31, 1991. Clinical Research 38(4):939A, 1990.

21. Carlson SE, Peeples JM, Werkman SH, Cooke RJ, Wilson WM: Plasma phosphatidylcholine

(PC) arachidonate (AA) concentrations of preterm (PT) infants during infancy: Growth and development, Poster presentation at FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), Atlanta, GA, April 24, 1991. FASEB Journal 5(5):A1320(#5506), 1991.

22. Cooke RJ, Carlson SE, Werkman SH, Peeples JM: Growth of premature infants in year one:

Effect of marine oil supplementation of formula, presented before FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), Atlanta, GA, April 23, 1991. FASEB Journal 5(5):A1072(#4072), 1991.

23. Werkman SH, Peeples JM, Carlson SE, Wilson WM, Cooke RJ: Vitamin A status at expected

delivery and growth and developmental scores of preterm infants during year one, presented (S. Werkman) before FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), Atlanta, GA, April 23, 1991. FASEB Journal 5(5):A1072(#4068), 1991.

24. Carlson SE, Cooke RJ, Peeples JM, Werkman SH: Vitamin A status of very low birth weight

(VLBW) infants maintained on preterm formula to 48 weeks postconception (PCA), presented before the Society for Pediatric Research, New Orleans, LA, May 2, 1991. Pediatric Research 29(4):292A(#1737), 1991.


35

25. Koo W, Walters J, Massom L, Chesney R, Blake R, Carlson S: Effect of movement artifact on dual energy x-ray absorptiometry measurement in infants, Poster presentation at the Southern Society for Pediatric Research (W. Koo), New Orleans, LA, February 4, 1994. Clinical Research 41(4):735A, 1993.

26. Rajaram S, Carlson SE, Koo WK, Braselton WE: Plasma zinc (Zn) concentrations from birth to

six months in term (T) and preterm (PT) infants, presented (S. Rajaram) before the FASEB (American Institute of Nutrition/American Society for Clinical Nutrition), Anaheim, CA, April 26, 1994. FASEB Journal 8(4):A460, 1994.

27. Carlson SE, Wilson WW III: Docosahexaenoic acid (DHA) supplementation of preterm (PT)

infants: Effect on the 12-month Bayley Mental Developmental Index (MDI), Poster presentation at the Society for Pediatric Research, Seattle, WA, May 2, 1994. Pediatric Research 35(4):20A(#104), 1994.

28. Werkman SH, Carlson SE: The Fagan Test of Infant Intelligence (FTII) and visual attention

during the FTII: Term and preterm infants fed term or preterm formula after hospital discharge, Poster presentation at the Society for Pediatric Research, Seattle, WA, May 2, 1994. Pediatric Research 35(4):28A(#156), 1994.

29. Rajaram S, Stene MA, Kelly DP, Carlson SE: Plasma insulin-like growth factor-I (IGF-I) and

IGF binding protein-3 (IGFBP-3) in term infants from birth to six months, Poster presentation at the Society for Pediatric Research, Seattle, WA, May 3, 1994. Pediatric Research 35(4):105A(#616), 1994.

30. Walters J, Koo WWK, Massom L, Carlson SE: Dual energy x-ray absorptiometry-based spine

bone mineral content: Comparison with whole body bone mineral content and normative data in newborn infants, presented before the American Society for Bone and Mineral Research, Kansas City, MO, September 10, 1994. Journal of Bone and Mineral Research 9(Suppl 1):S224, 1994.

31. Koo WWK, Walters J, Massom L, Carlson SE: Dual energy x-ray absorptiometry-based bone

mineral content (DXA-BMC): Influence of movement artifact and normative data in newborn infants, presented before the American Society for Bone and Mineral Research, Kansas City, MO, September 10, 1994. Journal of Bone and Mineral Research 9(Suppl 1):S349, 1994.

32. Carlson SE, Werkman SH: Preterm infants fed formula with compared to without

docosahexaenoic acid (DHA) have shorter look duration ten months after DHA is discontinued, Poster presentation at the Society for Pediatric Research, San Diego, CA, May 8, 1995. Pediatric Research 37(4):14A(#67), 1995.

33. Koo W, Walters J, Carlson S: Postnatal changes in bone mineralization for infants born at term,

presented (W. Koo) before the American Society for Bone and Mineral Research 17th Annual Meeting, Baltimore, MD, Sept. 1995. Journal of Bone and Mineral Research 10(Suppl 1):S295, 1995.

34. Koo W, Walters J, Carlson S: Delayed bone mineralization in preterm (PT) infants, presented

(W. Koo) before the American Society for Bone and Mineral Research 17th Annual Meeting, Baltimore, MD, Sept. 1995. Journal of Bone and Mineral Research 10(Suppl 1):S296, 1995.


36

35. Carlson SE: Early visual acuity does not correlate with later evidence of visual processing in preterm infants although each is improved by the addition of docosahexaenoic acid to infant formula, Poster presentation at the Second International Congress of the International Society for the Study of Fatty Acids and Lipids, Bethesda, MD, June 1995. Congress Program and Abstracts #53.

36. Ayyagari A, Peeples JM, Carlson SE: Maternal trans fatty acid intake and trans fatty acids in

plasma of mother-infant pairs, presented before Experimental Biology '96 (American Institute of Nutrition/American Society for Clinical Nutrition), Washington, DC, April 15, 1996. FASEB Journal 10(3):A190(#1097), 1996.

37. Ayyagari A, Peeples JM, Carlson SE: Relationship of isomeric fatty acids in human cord blood

to n3 and n6 status, Poster presentation at the Society for Pediatric Research, Washington, DC, May 9, 1996. Pediatric Research 39(4):304A(#1808), 1996.

38. Koo W, Walters J, Carlson S: Postnatal development of body composition of preterm infants,

Poster presentation (W. Koo) at the Society for Pediatric Research, Washington, DC, May 1996. Pediatric Research 39(4):223A(#1320), 1996.

39. Sargent TL, Smith MA, Carlson SE, Eck L, Yolton K: The role of nutrition in infant neurological

development: Outcomes of the Bayley Scales of Infant Development of infants provided supplemental n-3 fatty acids, presented (T. Sargent) before the American Dietetic Association, Chicago, IL, October 25, 1996. Journal of the American Dietetic Association 96(9):A-74, 1996.

40. Peeples JM, Werkman SH, Desiderio DM, Carlson SE: Effect of LCPUFA and age on red blood

cell sphingomyelin 24:1 n-9 and 24:2 of preterm infants with reference to term infants, presented (J. Peeples) before PUFA in Infant Nutrition: Consensus and Controversies, Barcelona, Spain, November 7, 1996. PUFA in Infant Nutrition: Consensus and Controversies Abstract Book, 1996, p. 33.

41. Werkman SH, Carlson SE: Novelty preference and look duration among term infants fed

human milk or diets varying in n-3 and n-6 LCPUFA, presented (S. Werkman) before PUFA in Infant Nutrition: Consensus and Controversies, Barcelona, Spain, November 7, 1996. PUFA in Infant Nutrition: Consensus and Controversies Abstract Book, 1996, p. 41.

42. Donley WE, Smith MA, Carlson SE, Eck L. Infant feeding practices during the weaning process

of inner-city mothers who chose to formula feed, presented (MA Smith) before the American Dietetic Association, Boston, MA, October 29, 1997. Journal of the American Dietetic Association 97:A-70, 1997.

43. Carlson SE, Montalto MB, Korones SB. Necrotizing enterocolitis (NEC) in preterm (PT) infants

fed formula with egg phospholipid (EPL) arachidonate (ARA) and docosahexaenoate (DHA) at the Society for Pediatric Research, New Orleans, LA, May 1998. Pediatric Research 43:99A, 1998.

37. Borod E, Atkinson R, Barclay WR, Carlson SE. Effects of third trimester consumption of eggs

high in DHA on DHA status and pregnancy. Lipids 34:S231, 1999.


37

38. Carlson SE, Werkman SH, Montalto MB, Tolley EA. Visual acuity development of preterm (PT) infants fed docosahexaenoic acid (DHA) and arachidonic acid (ARA): Effect of age at supplementation. Pediatric Research 45:279A, 1999.

39. Carlson SE. Mehra S, Kagey WJ, Merkel KL, Diersen-Schade DA, Harris CL, Hansen JW.

Growth and development of term infants fed formulas with docosahexaenoic acid (DHA) from algal oil or fish oil and arachidonic acid from fungal oil. Pediatric Research 45:278A, 1999.

40. Carlson SE: Very low birth weight preterm infants fed DHA-supplemented formulas: results of

three trials using three DHA sources. 4th Congres of the International Society for the Study of Fatty Acids and Lipids, Program and Abstracts, June 4-9, 2000, p. 154.

41. Smuts CM, Huang MI, Mundy DC, Carlson SE: Isomeric fatty acids in mothers and their infants:

A further exploration of relationships to DHA and AA in a new population with benefit of umbilical vessel wall fatty acids. PUFA in Maternal and Child Health, Program and Abstracts, Sept. 10-13, 2000, Kansas City, Missouri (Lipids, 2001 in press), p. 17

42. Smuts CM, Carlson SE: Relative effects of womens’ DHA status entering the third trimester of

pregnancy and third trimester DHA intake on infant DHA status at birth. Ibid, p. 41. 43. Smuts CM, Huang MI, Mundy D, Carlson SE: Essential fatty acids in maternal and newborn

phospholipids from a primarily African-American population in the United States. Ibid, p. 41. 44. Carlson SE: PUFA and growth: Resolving issues of n-3 and n-6 fatty acid balance. Ibid, 42. 45. Bogener J, Radel JD, Zhao J-P, Gaines JB, Carlson SE: Effect of a diet deficient in alpha-

linolenic acid on adult rat visual evoked potentials. Ibid, 4 (addendum). 46. Carlson SE, Gaines JB, Zhao J, Cui L, Choudhuri R, Berman NE: Effect of low brain

docosahexaenoic acid on gene expression in rat frontal cortex. Pediatr. Res. 49:294A, 2001 47. Radel JD, Bogener J, Zhao J-P, Gaines JB and Carlson SE. Effect of a diet deficient in alpha-

linolenic acid on adult rat visual evoked potentials. Poster presentation (Radel) at National ARVO Abstracts, May 2001.

48. Beyer PL, Meek L, Wismer K, Carlson SE. Need title. American College of Gastroenterology,

2002 49. Carlson SE, Huang M, Smuts CM, Mundy D, Plasse T, Major S. A randomized clinical trial of

DHA supplementation during the third trimester of pregnancy and pregnancy outcome. Platform presentation at joint meeting of AOCS/ISSFAL, Montreal, Canada, May 2002.

50. Radel JD, Levant B, Carlson SE: Effects of developmental DHA deficiency and remediation

upon evoked brain activity at maturity in rats. Poster presentation (Radel) at Neurosciences meeting in Orlando, FL, November 2002. Program No. 106.5 2002 Abstracts Viewer/Itinerary Planner. Washington DC: Society for Neuroscience, CD-ROM.

51. Levant B, Radel JD, Grasing K, Richards TL, Carlson SE. Effects of developmental DHA

deficiency and remediation on adult behavior in rats. Poster presentation (Levant) at


38

Neurosciences meeting in Orlando, FL, November 2002. Program No. 106.5 2002 Abstracts Viewer/Itinerary Planner. Washington DC: Society for Neuroscience, CD-ROM.

52. Gaskill TR, Smuts CM, Carlson SE. Maternal trans-fatty acid levels and infant

docosahexaenoate (DHA) status at parturition. FASEB Abstracts 2003. 53. Carlson SE, Colombo J, Shjaddy DJ, Maikranz JM, Kundurthi S, Anderson CJ, Kannass KN,

Blaga OM. Maternal DHA levels and the development of attention. Society for Research in Child Development Abstracts 2003.

54. Radel J, Levant B, Carlson S. Correlation of altered evoked neural activity at maturity and brain

DHA levels during early development: A reversibility study in rats. Maternal and Infant LCPUFA Workshop, Kansas City, MO, May 2003.

55. Levant B, Radel J, Carlson S. Decreased brain docosahexaenoic acid during development

alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Ibid.

56. Gaines J, Levant B, Radel J, Berman N, Carlson S. Anterior cerebral gene expression in a rat

model of “physiologically relevant” DHA reduction. Ibid. 57. Carlson SE. The role of LCPUFA (DHA+ARA) in Infant Development, Fukuoka, Japan, May

2003. 58. Carlson SE. Maternal long chain fatty acid metabolism and nutrition: Influences on pregnancy

outcome and neonatal development. Mother and Infant Conference, Montreal, Canada, June 2003.

59. Carlson SE. Human milk as a model for infant formula. Bristol-Myers Squibb/Mead Johnson

Colloquiium, New Harmony, IN, June 2003. 60. Kundurthi S, Sullivan DK, Carlson SE. Occurrence of overweight and contributing factors in

infants and toddlers. North American Association for the Study of Obesity, Nov. 2003. 61. Beyer PL, Carlson SE, McCallum RW. Prevalence of GI symptoms in persons with diabetes and

age-gender matched controls. American College of Gastroenterology, November 2003. 62. Klein RM, Liverman CS, Carlson SE, Berman NE. Grape-enriched dieet upregulates

transthyretin in aged mouse brain : Potential protection from Alzheimer’s disease? November 2007 Neuroscience meeting, Program#/Poster #: 256.17/N27.

Except for 96, no abstracts have been added since 2004

UNIVERSITY COMMITTEES AND OFFICES HELD: Member, Committee on Undergraduate Education, The University of Tennessee, Memphis, 12/1/91-8/97 Member, Clinical Research Center Scientific Advisory Committee, The University of Tennessee,

Memphis, 6/92-8/97 Member, Faculty Senate, Department of Pediatrics, The University of Tennessee, Memphis, 5/94-6/97


39

Faculty Senate Executive Committee representing College of Medicine, The University of Tennessee, Memphis, 5/94-6/97

Member, Institutional Review Board, Le Bonheur Children's Medical Center, 5/95-8/97 Member, Search Committee for Associate Vice Chancellor for Development, The University of

Tennessee, 1995 Member, Search Committee for Executive Vice Chancellor, The University of Tennessee, 1996 Member, College of Medicine, Dean’s Advisory Committee, 1996-1997 Member, Institutional Biosafety Committee, University of Missouri-Kansas City, 1997 – Present Member, UMKC Pediatric Institutional Review Board (Childrens’ Mercy Hospital), 1999 Member, KUMC Faculty Affairs Research Committee (FARC), 2000-2003, 2009-2012,

Chair 2010- 2011Committee reviewer for KUMC Research awards 2001 for Hall Foundation Collaborative Grants from Children’s Mercy Hospital and KUMC, 2001.

Member KUMC Human Subjects Committee 2001 to 2008 Member KUMRI Advisory Committee, 2003 – 2004 (work completed in 2004) Member Faculty Assembly Steering Committee, 2005-2008; reelected 2008 - 2010 (Chair, 2008-2009) Member Faculty Assembly Resources and Planning Committee, 2005- 2008 Member EVC Budget Advisory Committee representing faculty governance, Spring 2009 Director, KUMC Biomedical Research Careers in Women’s Health (NIH) – 2010-present Co-Chair, KUMC Dean search for School of Health Professions - 2015 SCHOOL AND DEPARTMENT COMMITTEES AND OFFICES HELD Member, Search Committee for Missouri Endowed Professorship for Cultural Diversity, UMKC School of Nursing, 1998 - 1999 Member, APT Committee, UMKC School of Nursing, 1998 - 1999 Member, Diversity Committee, School of Allied Health, 2000-Present (Participated in 7th Annual

Regents’ Michael Tilford Conference on Diversity and Multiculturalism, Oct. 26-27, 2000). Member, Interdisciplinary Committee, School of Allied Health, 2000-2005 Member, Search for D&N Chairperson, School of Allied Health, 2003 Chair, D&N Faculty Search, 2005 Director, Dept. of Dietetics and Nutrition PhD program in Medical Nutrition Science, 2009-present Member, School of Allied Health Research Committee, 2005-2008; Chair 2007-2008. CME/Local: 1. "Maternal and Infant Nutrition", Workshop on Maternal and Infant Nutrition Mississippi Public Health Association, Biloxi, Mississippi, May 1983 2. "Support of the Breast Feeding Mother", Seventh Annual Mississippi Perinatal Postgraduate

Course, Jackson, Mississippi, December 6, 1985 3. "Nutritional Aspect of Breast Feeding", Mississippi Dietetic Association, 39th Annual Meeting Jackson, Mississippi, April 16, 1986 4. "Follow-up Nutritional Care of Preterm Infants", Central Mississippi Pediatric Society Jackson, Mississippi, September 23, 1986. 5. "Breastfeeding the Premature Infant", Nutrition '87 - What Are the Choices? Memphis Area

Nutrition Council Symposium XVIII, Memphis, Tennessee, May 7, 1987 6. "Nutrition for the 1990s", Wyeth Laboratories CME Program, Osage Beach, Missouri August 20, 1988 7. "Pediatric Nutrition", Family Practice Residents, Jackson, Tennessee, May 10, 1989


40

8. Co-Chairman: Clinical Nutrition, Southern Society for Pediatric Research, New Orleans, Louisiana, January 18, 1990

9. "N-3 Fatty Acids and Visual Acuity in Developing Infants", Department of Biochemistry Seminar The University of Tennessee, Memphis, Memphis, Tennessee, May 17, 1990 10. "Simplifying Nutritional Advice to Parents", Grand Rounds, Department of Pediatrics The University of Tennessee, Memphis/LeBonheur Children's, Medical Center, Memphis,

Tennessee, August 22, 1990 11. "Vitamin A Deficiency: Frequency and Consequences to Growth and Development of

Premature Infants", Twenty-second Memphis Conference on the Mother, Fetus, and Newb orn, The University of Tennessee, Memphis, Memphis, Tennessee, September 27, 1990 12. "Preventable Cancers", Focus for the 90's: Cancer Prevention and Control, American Cancer

Society, Nashville, Tennessee, April 5, 1991 13. "Role of Essential Fatty Acid Metabolism in the Growth and Development of the Premature

Newborn Infant", Department of Physiology and Biophysics, The University of Tennessee, Memphis, Memphis, Tennessee, January 13, 1992

14. "Growth and Development of Premature Infants Related to N-3 and N-6 Fatty Acids" Departments of Biochemistry and Pediatrics, University of Mississippi Medical Center Jackson, Mississippi, December 9, 1992 15. "Nutrition: Biochemistry and Function", M-1 Medical Students, University of Mississippi Medical

Center, Jackson, Mississippi, December 9, 1992 16. "The Effect of Dietary n-3 Fatty Acid Status on Visual Acuity in Preterm Infants", Southern

College of Optometry, Memphis, Tennessee, January 13, 1993 17. "Nutritional Management of the Low-Birth-Weight Infant" Eleventh Annual Tennessee Conference on Perinatal and Neonatal Care The Tennessee Perinatal Care System, Tennessee Department of Health and Environment, Nashville, Tennessee, March 2, 1993 18. "The Role of N-3 Fatty Acids in Visual Function of Preterm Infants" Fifth Annual Research Day in Vision and Ophthalmology, Department of Ophthalmology, The

University of Tennessee, Memphis, Memphis, Tennessee, May 14, 1993 19. "Nutrition in Very-Low-Birth Weight Infants", Sixth Annual Symposium, Memphis Area Society

for Parenteral and Enteral Nutrition, Memphis, Tennessee, May 21, 1993 20. "Role of Essential Fatty Acids in Infant Development", Pediatric Grand Rounds, University of

Mississippi Medical Center, Jackson, Mississippi, February 15, 1995 21. "Clinic al Trials Studying n-3 and n-6 Fatty Acids", Sigma Xi Lecture, University of Mississippi

Medical Center, Jackson, Mississippi, February 16, 1995 39. "Post-Discharge Nutrition for Preterm Infants”, Twenty-seventh Memphis Conference on the Newborn, The University of Tennessee, Memphis, Memphis, Tennessee, September 13, 1996 23. “Dietary Lipids and Infant Development: Consensus and Controversy”, Noon Research

Seminar, Children’s Mercy Hospital, Kansas City, Missouri, February 5, 1999 24. “Nutrition for Patients with HIV, Trinity Lutheran Hospital Foundation Grant, Kansas City,

Missouri, March, 24, 1999; June 16, 1999 25. America’s Calcium Crisis, Calcium Summit, Kansas City, MO, April 18, 2000 26. “America’s Crisis in Child Nutrition: Advocating for Children before Intervention is Needed.”

Workshop for 24th Annual Governor’s Conference for the Prevention of Child Abuse and Neglect: Teaming up to keep kids safe at home, Topeka, KS, October 20, 2000

27. “Unraveling the Mysteries of DHA in Neural Function”, Sigma Xi Seminar, KUMC, Kansas City, KS, November 15, 2000

28. DASH and DASH-Sodium Diets, Kansas Dietetic Association, Manhattan, KS, March 30, 2001 29. DHA in Functional Foods and Dietary Supplements, KUMC Dept. of Dietetics and Nutrition CME

Course, Kansas City, KS, June 29, 2001


41

30. LCPUFA and Infant Development, Pediatric Grand Rounds, KUMC, Feb. 2002 31. DHA for Moms and Babies, Pediatric Grand Rounds, KUMC, January 2005

Except for the last two talks in this list, I have not added local talks to my CV since 2001.

CURRICULUM VITAE NAME - University of Kansas Hospital€¦ · CURRICULUM VITAE NAME: ... Organizer...

Documents

Transcript of CURRICULUM VITAE NAME - University of Kansas Hospital€¦ · CURRICULUM VITAE NAME: ... Organizer...